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Abstract 
DNA methylation is a critical component of gene control, and is maintained by a 
family of of enzymes called the DNA methyltransferases. Methylation of CpG sequences 
promotes the formation of stably condensed, repressed chromatin. This process is 
important during development where DNA methylation is thought to have a role in 
lineage determination, X-chromosome inactivation, imprinting, and silencing of 
endogenous parasitic elements. 
Our aim is to examine the role of methylation in gene silencing during vertebrate 
development using the zebrafish as a model. To this end we have identified and isolated 
a number of de novo DNA methyltransferase (dnmt3) gene sequences from the zebrafish 
(Dania rerio) and determined the relative expression levels of each during a variety of 
developmental stages. The zebrafish has six de novo DNA methyltransferase genes as 
opposed to the three found in mammals. In order to characterize the roles of the dnmt 
genes we have performed knockdown analysis by morpholino injection. In addition we 
have treated embryos with a methylation blocker, 5-aza-2' -deoxycytidine in order to 
examine effects of overall methylation disruption. Based on results from both of these 
approaches, we conclude that normal methylation is critical to notochord differentiation 
and development. Other processes where methylation may be relevant include heart, and 
central nervous system (CNS) development. Preliminary microarray experiments suggest 
a number of genes that are directly or indirectly regulated by methylation that may be 
pursued for further investigations of DNA methylation. 
II 
This work will not only allow us to use the zebrafi h to examme the role of 
methylation in vertebrate development, but also develop it as a well-suited model for 
examining di ea es related to abnormal methylation. 
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Chapter 1: General Introduction 
1 
1.1 Epigenetics 
The cells of our body differ from each other in order to make it possible to carry out 
a vast array of different functions. This is the very essence of multicellularity. However, 
with only a very few exceptions, each cell carries the full complement of DNA. The 
difference, therefore, from cell type to cell type in one individual is not a reflection of the 
DNA that is housed in the nuclei, but rather in the genes that are expressed. The control 
of gene expression at the transcript level in vertebrate cells may be broadly divided into 
three categories: 1) intrinsic promoter strength and availability of core transcription 
machinery, 2) the actions of promoter specific transcription factors, and 3) the control of 
DNA accessibility by altering chromatin structure (Cheng and Blummenthal 2008). The 
latter, and the focus of this thesis, is the least understood of these categories, and pertains 
to the study of epigenetics. 
With entire genomes now sequenced, we are faced with the challenge of 
understanding how the genetic program is read (Bernstein et al. 2007). "Epi" means "on 
top of', so epigenetic literally means on top of the "genetic" layer. We are in the very 
early stages of understanding this superimposed layer of infom1ation, and even long held 
beliefs in this field are being challenged by recent findings (Metivier et al. 2008; Suzuki 
and Bird 2008). What can be stated, though, is that through regulation of chromatin 
structure and DNA accessibility, epigenetics modulate genome function (Bernstein et al. 
2007). To give an idea of the complexities we face in understanding this area and its 
implications, something worth pondering is the fact that, though there is one genome in 
2 
an individual, there are as many epigenomes as there are types of cell (Suzuki and Bird 
2008). 
Defining epigenetics beyond its literal sense becomes more complicated. The 
journal Nature recently touched on the controversy surrounding the term "epigenetics," 
and what it means, in an article featuring the most disputed definitions in science 
(Pearson 2008). One unanimously agreed upon aspect in the field, however, is that DNA 
methylation classifies as an epigenetic phenomenon, satisfying as it does the classical 
definition of "the study of mitotically and/or meiotically heritable changes in gene 
function that cannot be explained by changes in DNA sequence" (Riggs et al., 1996 
quoted in (Felsenfeld 2006) p.l6). 
In eukaryotic cells chromatin consists of DNA tightly associated with histone 
proteins. Some broader definitions of "epigenetics" allow for the inclusion of 
modifications that are made to such proteins (Bernstein et al. 2007). The functional unit 
of chromatin consists of approximately 146 base pairs of DNA wrapped around an 
octamer containing two copies of core histones, H2A, H2B, H3, and H4. In the recent 
past, histone proteins were simply thought of as spools onto which DNA was wound to 
allow compact packaging of hereditary material. It is becoming increasingly clear, 
however, that the marks laid down on the histone tails result in a much more extensive 
role for histones than simple spools, and in fact play an important signalling role in the 
cell (Sims et al. 2003). 
One criticism of the classification of histone protein modifications as epigenetic is 
the lack of evidence for heritability of these marks. Nevertheless, the term "epigenome" 
may be loosely used to refer to cytosine methylation as well as the fu ll repertoire of 
3 
histone modifications, with the understanding that only a subset of histone modifications 
may ever demonstrate epigenetic inheritance (Bernstein et al. 2007). And regardless of 
these nuances, what is clear is that the genomes of many eukaryotes carry these 
epigenetic marks and, interestingly, that they are not applied uniformly. Rather, they are 
laid down in patterns, and either signal and/or preserve local activity states, such as 
transcription or silencing (Suzuki and Bird 2008). 
In eukaryotes, DNA methylation is the only known modification to actually occur 
on the DNA. In vertebrates this occurs almost exclusively at CpG dinucleotides (CpG 
denotes a cytosine that occurs next to guanine in the nucleotide sequence and these 
nucleotides are separated by a phosphate. This representation allows for distinction from 
CG base-pairing). Approximately 60%- 80% of all CpGs in the vertebrate genome are 
methylated (Chen and Li 2006; Bernstein et al. 2007). In contrast, there are more than 
100 modifications including acetylation, methylation, phosphorylation, and ubiquitination 
that may be made to the histone proteins (Bernstein et al. 2007). 
If we are to dissect and understand the biological significance of epigenetic 
phenomena, it is obviously critical to have a thorough understanding of not only the 
patterns that are laid down, but also how these patterns are established, maintained, and/or 
altered (Suzuki and Bird 2008). In this regard, a thorough knowledge of the enzymes that 
lay down these patterns is essential. There remain many questions surrounding what 
targets these enzymes, their control, their functional specificities as well as the overlap 
among them, their interactions, and the cross-talk that may occur between epigenetic 
layers. Only with these areas well in hand will we be properly equipped to address the 
physiological, developmental, evolutionary and biomedical significance of these 
4 
phenomena. With an appreciation for the various epigenome of different cell types, and 
how they are laid down, we may distinguish normal state epigenome from disease tate 
epigenomes, under tand how these tran ition occur, and eventually be able to reverse, or 
even prevent these transitions. 
1.2 DNA Methylation 
DNA methylation is a suppre tve mark. Though a deceptively simple 
modification, the addition of a methyl group to the 5-position of cyto ine to give 5-
methylcyto ine (Figure 1.1) has a profound effect in a growing list of proces es including 
tissue-specific gene expression (Oka et al. 2005), cell differentiation (Wu and Sun 2006), 
genomic imprinting (Smjth et al. 2006), X-chromosome inactivation (Barr et al. 2007), 
developmental origins (Waterland and Jirtle 2004), genome defence and stability (Walsh 
et al. 1998), learning and memory (Levenson eta/. 2006), carcinogenesis (Esteller eta/. 
2001 ), mental disorders (Mill et al. 2008), and aging (Casilla et al. 2003). 
CpG methylation of promoter regions re ults in long term si lencing of the 
associated gene through several mechani m (Figure J .2). In some instances, methylation 
may preclude recruitment of regulatory proteins by directly impeding the binding of 
transcription factor and thereby suppre sing gene expression (Bird 2002). Alternatively, 
methylation effects may be mediated through the recruitment of regulatory proteins such 
as methyl-CpG-binding proteins, which in turn recruit histone deacetylases (Razin J 998). 
Histone deacetylation leads to the compaction of chromatin, rendering the chromatin 
inaccessible to tran criptional machjnery. 
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Chromatin that is densely packed and said to be in a closed state refractive of 
expression is referred to as "heterochromatin", while chromatin that is relatively le 
compacted, aid to be in an open tate and at least potentially active, as it i acce sible to 
transcriptional machinery, is referred to as euchromatin (Lewin 2002). Given DNA 
methylation and histone deacetylation lead to heterochromatin formation, and/or are 
involved in maintenance of this inactive tate, heterochromatin is characterized by den e 
DNA methylation and deacetylated histones. Heterochromatin may be categorized as 
constitutive or facultative. In in tance where the region of DNA i invariably 
heterochromatic, i.e. centromeric, pericentric, and telomeric regions, DNA methylation i 
referred to as constitutive. An example of facultative heterochromatin on the other hand 
is X-inactivation in mammals, where the inactive X-chromosome is heterochromatic, and 
the active X-chromosome, even though it ha identical sequence, is part of euchromatin. 
Regardless of whether heterochromatin i con titutive or facultative, the chromatin 
characterized by dense DNA methylation and deacetylated hi tone (Lewin 2002). 
Although the majority of CpG ites are methylated across the mammalian genome, 
regions relatively free of methylation, referred to as CpG islands, are found in the 
promoter regions of, for example, approximately 60%-75% of human genes (Chen and Li 
2006; Bern tein et al. 2007). A common suggestion in the literature, and one that ha 
been challenged in more recent years, i that CpG island are alway unmethylated, with 
the exception of those in the inactivated X-chromosome, imprinted genes, and tumour 
suppressor loci in age related cancers. However, a growing li t of gene with ti ue-
specific expression containing CpG islands have been shown to be methylated during 
development (Oka et al. 2005). 
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CpG islands may be defined as sequences greater than 200 bp which are enriched 
for CpG dinucleotides (G+C content greater than 50%). CpG islands are most commonly 
found in the promoter regions of housekeeping genes, though they are also present in 
approximately half of genes that have tissue-specific transcript expression (Goll and 
Bestor 2005). 
1.3 The DNA Methyltransferases 
The enzymes responsible for carrying out methylation of the cytosine base in CpG 
dinucleotides sequences are the cytosine-5 methyltransferases (Figure 1.3). Thus far, fi ve 
mammalian DNA methyltransferases (Dnmts) have been identified (Meehan 2003). 
However, the activities of the enzymes may be broken into two main groups, maintenance 
methylation by DNA methyltransferase 1 (Dnmtl), and de novo methylation, performed 
mainly by the DNA methyltransferase 3 family (Dnmt3), also referred to as the de novo 
methyltransferases. The Dnmt3 family is comprised of two catalytically active enzymes, 
Dnmt3a and Dnmt3b, while the third member, Dnmt31, is catalytically inactive on its 
own, yet acts as an essential co-factor (Robertson 2001). Dnmt2, the most widely 
conserved of the methyltransferase families (Meehan 2003), is likely to have a role as a 
tRNA methyltransferase, and investigations of its function as a DNA methyltransferase 
are still ongoing (Rai et al. 2007). 
The defining aspect of cytosine-5 methyltransferases is the presence of up to 10 
conserved motifs in the C-terminal catalytic domain, and a number of other common 
motifs (Figure 1.3) (Chen and Riggs 2005). Summaries of the current state of knowledge 
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for the maintenance methyltransfera e, as well as Dnmt3a and Dnmt3b, are provided 
below. Critical areas requiring closer examination for a more complete understanding of 
DNA methylation, particularly with its relevance to development, are highlighted. 
a) Dnmtl 
One of the features of DNA methylation is that the mark is stable and heritable 
through cell divi ion (Figure 1.4). Therefore, CpG dinucleotides that are converted to the 
hemimethylated tate during DNA replication must be faithfully replicated to the 
daughter DNA strand in order to prevent passive loss of these marks. Dnmtl i 
considered a maintenance methyltransferase based on both in vitro and in vivo evidence. 
Dnmtl shows a 5-40 fold preference for hemimethylated v . unmethylated DNA in vitro 
(Turek-Plewa and Jagodzinski 2005). Expression of Dnmt l at the transcript level is 
consistent with its role as a maintenance methyltransferase as it is highly expressed in 
proliferating cells and is ubiquitou ly expres ed in somatic cell (Brenner and Fuks 
2006). Additional upport for the function of Dnmtl as a maintenance methyltransferase 
comes from in vivo studies showing localization of Dnmtl to DNA replication foci during 
S phase and interaction with the DNA polymerase processivity factor proliferating cell 
nuclear antigen (PCNA). As well , inactivation of Dnmtl re ults in widespread 
demethylation of examined sequences, but does not affect de novo methylation of newly 
integrated retroviral DNA (Chen and Li 2006). 
Several areas of research are ongoing to investigate the role(s) of Dnmtl in 
development. Particular interest is centered on its role in maintaining imprinted genes 
through a wave of demethylation during mammalian development (Dean 2008), its 
interactions with other epigenetic layers (Esteve et al. 2006), and a study in zebrafish ha 
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provided evidence for dnmtl as having a role in terminal differentiation in a number of 
vertebrate tissues (Rai et al. 2006). 
b) Dnmt3 Family 
The Dnmt3 farruly is of significant interest as these enzymes establish the 
methylation patterns during gametogenesis and early embryogenesis (Figure 1.4). There 
are only two catalytically active members in this family: Dnmt3a and Dnmt3b. Despite 
Dnmt3l's similarity to Dnmt3a and Dnmt3b, it lacks some of the critical catalytic motifs, 
rendering it inactive. 
Expression patterns of Dnmt3a and Dnmt3b are consistent with their proposed role 
as de novo methylating enzymes. For instance, both are highly expressed in embryonic 
stem (ES) cells (Okano et al. 1998), early embryos (Watanabe et al. 2002), and 
developing germ cells (Lees-Murdock et al. 2005), - all instances where de novo 
methylation takes place. On the other hand, they are downregulated in somatic tissues of 
postnatal animals, where one can expect fewer requirements for de novo methylation 
(Okano et al. 1999). Additional support for these being de novo methyltransferases is 
given by the fact that de novo methylation is disrupted when Dnmt3a and Dnmt3b are 
inactivated by gene targeting in ES cells as well as in early embryos (Okano et al. 1999). 
Additionally, de novo methylation results when Dnmt3a and Dnmt3b are over-expressed 
in mammalian cells or transgenic flies (Lyko et al. 1999). More recently, Dnmt3a and 
Dnm3l have been shown to be essential for the establishment of methylation imprints 
during gametogenesis (Kaneda et al. 2004). Although Dnmt3l is catalytically inactive, it 
likely has a role in targeting of Dnmt3a to particular genorruc regions. Collectively, these 
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findings provide strong evidence for Dnmt3a and Dnmt3b as de novo methylating 
enzymes that establish DNA methylation patterns during embryogenesis and 
gametogenesis. 
There is evidence, however, that both Dnmt3a and Dnmt3b may also have a role in 
maintaining methylation levels along with dnmtl, and there is support for interaction 
among all of these proteins. These interactions and their significance are not well 
understood (Chen and Li 2006). 
The critical nature of de novo methylation in development has probably been most 
dramatically demonstrated in studies employing knockout techniques in mice where 
Dnmt3a null mice are undersized and die within 4 weeks of birth, and Dnmt3b null mice 
do not even develop to term (Okano et al. 1999; Meehan 2003). Although Dnmt3l 
deficient females are normal, the embryos derived from those females do not develop to 
term, and are lacking maternal-specific imprints (Kaneda et al. 2004). All of the above 
demonstrate very clearly that the Dnmt enzymes play a very fundamental and critical role 
in normal and abnormal mouse development. 
We may gain some insight into the role of the de novo dnmts and their targeting 
from their structure (Figure 1.3). Dnmts generally are comprised of two domains: a 
highly conserved catalytic domain in the C-terminal region, and a more variable 
regulatory domain in theN-terminal domain (Brenner and Fuks 2006). Both Dnmt3a and 
Dnmt3b have in their N-terminal regulatory domains a variable region, a PWWP 
(Proline-Tryptophan-Tryptophan-Proline) domain, and a cysteine-rich region PHD (Plant 
homeodomain) (Chen and Li 2006). The catal ytic domain, on the other hand, contains up 
to ten characteristic motifs, of which six are highly conserved, carrying out various steps 
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including binding cytosine and the methyl-donor S-adenosyl methionine (SAM) (Turek-
Plewa and Jagodzinski 2005). 
The PWWP domain, which consists of 100-150 amino acids contai ning a highly 
conserved PWWP motif, is likely to have a functional significance in targeting the 
Dnmt3s to pericentric heterochromatin. The significance of this motif has been revealed 
by the human disorder Immunodeficiency, Centromeric Instability, and Facial Anomalies 
(ICF) syndrome. Although the majority of mutations in DNMT3B causing ICF are 
located in the C-terrninal catalytic domain, in a couple of instances missense mutations 
were shown to occur in the DNMT3B PWWP domain. When analogous mutations in 
mouse cells were examined, a lack of constitutive pericentric heterochromatin targeting 
was found (Ehrlich et al. 2008). 
People suffering from ICF have characteristic chromosomal abnormalities such as 
chromatin decondensation, rearrangements, and DNA hypomethylation, specifically in 
the pericentric chromatin of chromosomes 1, 9, and 16. Patients have high mortality in 
childhood due to immunodeficiency, and also usually display facial anomalies such as 
broad flat nasal bridge, widely spaced eyes, and low set ears (Ehrlich et al. 2008). Mental 
retardation has been observed in about one-third of the patients with ICF (Ehrlich et al. 
2008). 
The conserved Plant Homeodomain is present in all three members of the dnmt3 
family. This domain is involved in protein-protein interactions. Examples discovered to 
date include interactions with transcription factors Myc and RP58, as well as interactions 
with heterochromatin protein HPI, histone deacetylases (HDACs), and the histone 
methyl transferase Suv39h 1 (Chen and Li 2006). These interactions are particularly 
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interesting as they provide mechanistic links that could explain some of the already 
indicated cross-talk between epigenetic layers; again, however, much research is needed 
before an understanding of the functional significance of these interactions will be 
achieved. 
Splice variants and promoter specific variants have been identified for both the 
Dnmt3a and Dnmt3b genes in mice and humans (Figure 1.5) (Meehan, 2003). In fact, 
there are two variants of Dnmt3a, and six Dnmt3b isoforms (Hermann et al. 2004 ). An 
emerging consideration is that the number of isoforms (Meehan, 2003), and the 
differences in their timing and levels of expression is a source of functional diversity for 
the Dnmt3 genes (Li, 2002). Discerning the role of each gene and isoform will no doubt 
provide great insights into how methylation patterns are established (Li, 2002). 
The difference in localization between Dnmt3a and Dnmt3a2, a Dnmt3a isoform 
that lacks the variable region, highlights the diversity that may result depending on 
presence or absence of particular motifs. Dnmt3a2 displays a diffuse nuclear localization 
pattern, while Dnmt3a is targeted to heterochromatin regions (Chen and Li 2006). This 
not only suggests the variable region of Dnmt3a is involved in heterochromatin targeting, 
but also implicates Dnmt3a2 as a gene-specific DNA methyltransferase since it is 
diffusely localized. Clearly, discovering which genes are being targeted, and the timing 
of these events will provide critical insight into the developmental program. 
Despite some knowledge concerning a number of the dnmt structural features, there 
is still much to be learned as to the specific roles each of the methyltransferases has in 
establishing methylation patterns and how they are regulated. Given that dnmts do not 
appear to have any sequence specificity beyond CpG dinucleotides, the question also 
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remains as to what specific interactions allow these enzymes to target specific sequences. 
That this challenge is being met is illustrated by the significant interest shown in the 
interacting proteins of the dnmts and, indeed, a handful of these interacting proteins have 
been identified, some of which are mentioned in the above paragraphs, which are 
involved in regulation of chromatin structure and gene expression (Chen and Li 2006). 
1.4 Mechanism of Methylation 
The mechanism of DNA methylation involves binding of the methyltransferase to 
the DNA, and in a process referred to as "base flipping" the cytosine is everted so that it 
projects out of the double helix (Figure 1.6) (Voet and Voet 2004). This is followed by 
the covalent attack of a conserved Cys nucleophile on cytosine carbon 6, a methyl group 
is transferred from the methyl donor SAM to the activated cytosine carbon 5, and this is 
then followed by the release steps (Cheng and Blummenthal 2008). This unusual 
mechanism is necessary to create an unstable intermediate in order to methylate the 
relatively unreactive fifth position on cytosine in the DNA. 
1.5 Methylation Dynamics in Vertebrate Development 
DNA methylation is required for normal development in mammals, and likely all 
vertebrates. Dynamic methylation changes are seen during development, involving whole 
genome demethylation and de novo methylation (Figure 1.7) (Reik et al. 2001). Both 
sperm and ova DNA have been demonstrated to be highly methylated in mammals, 
however, upon fertilization, the paternal genome undergoes rapid, active demethylation. 
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While the maternal genome also undergoes a wave of demethylation, in contrast to the 
active demethylation of the paternal genome, demethylation here is in keeping with a 
passive process, where maintenance methylation is not copied onto the daughter strand 
following replication (Dean 2008). This reprogramming of gamete DNA occurs genome-
wide, with the exception of imprinted genes in mammals that maintain their methylation 
status throughout this process. Following implantation, a wave of de novo methylation 
occurs, establishing a new embryonic methylation pattern that is maintained in the adult 
(Dean 2008). These events are believed to be critical in establishing patterns of gene 
expression and consequently driving cell lineage determination (Li 2002). 
1.6 Zebrafish as a Model for Development 
The zebrafish was selected as a developmental model during the 1980's by George 
Streisinger at the University of Oregon based on several important attributes and since 
then, these small freshwater teleosts have attained a prominent place in vertebrate 
development research. A number of the traits that bring this model to the forefront of 
development research are the very ones we have used here to gain understanding of the 
DNA methyltransferases in development. 
Practically, zebrafish are favourable for their ease in care and space requirements 
(Figure 1.8), and the fact that, when kept on a specific light cycle (14 hours light, 10 
hours dark), they breed within the first hour of the light cycle -what would be dawn in the 
wild. Zebrafish have a high fecundity and only a three-month generation time (Figure 
1.8). Most importantly, however, external fertilization and optically clear embryos 
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greatly facilitate observation of development, including both normal development and 
potentially subtle abnormalities following experimental manipulation (Figure 1.9) 
(Grunwald and Eisen 2002). 
Rapid ontogeny is another practical attribute of zebrafish for developmental studies 
(Link and Megason 2008). Following fertilization, cytoplasmjc streaming begins, 
whereby a large blastodisc is formed on top of the yolk (Figure 1.9A). Synchronous cell 
divisions occur for the next two and three-quarter to three hours (when embryos develop 
at 28.5 °C). At 2.75 hpf (hours post fertilization), the blastodisc is at the 512-cell stage; 
until this point cell divisions are synchronous, and no cell growth takes place giving rise 
to an increasing number of cells of decreased size (Schier and Talbot 2005). This 
division without growth leads to a critical threshold of DNA:cytoplasm ratio for cells, and 
division becomes asynchronous during the mjd-blastula transition (MBT, panel j). This 
marks the activation of the zygotic genome which will now govern development, though 
some zygotic genes do become active prior to this point (Schier and Talbot 2005). 
At approximately 5 hpf, zebrafish blastulas enter gastrulation (Figure 1.9A). By the 
process of epiboly, the blastoderm thins and spreads over the yolk, until, by the end of 
gastrulation, the blastoderm completely covers the yolk (Link and Megason 2008). By 6 
hpf, a thickening at the dorsal blastoderm margin (Figure 1.9A panels q and r indicate 
margin and shield) is apparent as a result of dorsal accumulation of cells by convergence 
and extension. This thickening, referred to as the shield, is the analogous structure to the 
node of mammals or Spemann-Mangold organizer of amphibians (Webb and Miller 
2007). By 10 hpf somjtogenesis has begun, and by 24 hpf the major subdivisions of the 
nervous system are in place. As well, rudiments for the primary organs are in place and 
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at this point in zebrafish development, and the heart begins beating. Organogenesis is 
complete by 72 hpf, and embryos are capable of swimming. For the first 5 days of 
development, nutrition is provided to the embryo by the yolk, however, at 5 days post-
fertilization, larval zebrafish begin foraging and feed externally (Link and Megason 
2008). Although pigmentation begins at 24 hours of development, later stages can be 
rendered transparent if desired with the use of melanin synthesis inhibitors (Link and 
Megason 2008). The molecular events that orchestrate these processes of morphogenesis 
and organogenesis are largely conserved to processes in humans, making zebrafish an 
excellent model for the study of fundamental processes of development, disease 
modeling, and drug evaluation (Chen and Ekker 2004). 
1. 7 The Zebrafish Genome 
The zebrafish genome is diploid, and its estimated size is 1600 Megabases (Mb) 
(Link and Megason 2008). There are 25 paired chromosomes which have been 
assembled by the Sanger Center (http://www.sanger.ac.uk/Projects/D_rerio/). The 
conserved synteny that is observed between zebrafish and humans is actually even greater 
than between humans and mouse, which have undergone extensive chromosome 
rearrangements (Dahm 2002). One trait that is important to be mindful of when analysing 
gene function in this model, however, is that during teleost evolution the genome 
underwent a genome duplication followed by massive gene loss that has resulted in 
duplicate gene representation of approximately 30% of genes in zebrafish compared to 
mammalian orthologs (Postlewait et al. , 1998). This event is estimated to have occurred 
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approximately 450 million years ago. Based on studies to date, the general rule appears 
to be that the divergence of duplicated genes in zebrafish has been most observed in the 
control regions and not as much in functional divergence, though certainly there are likely 
some exceptions (Link and Megason 2008). 
1.8 Zebrafish and Epigenetics 
Several lines of evidence are emerging which indicate DNA methylation, and 
epigenetics in general, play a critical role in zebrafish development, as they do in 
mammals. Zebrafish have an identified dnmtl (Mhanni et al. 2001 ), dnmt2 (Rai et al. 
2007), and six de novo methyltransferases that are homologous to mammalian Dnmt3a 
and Dnmt3b (Shimoda et al. 2005; Smith et al. 2005). Zebrafish do not have an identified 
dnmt3l, and do not imprint genes in development. With the presence of the de novo DNA 
methyltransferases, and the many genes implicated with the histone code, we may first 
characterize this system, but more interestingly, we may delve into explorations of 
function of epigenetics in development and beyond. 
One of the major pieces of evidence that DNA methylation has a role in zebrafish 
development comes from examining genomjc methylation changes during development 
(Mhanni and McGowan 2004; Mackay et al. 2007). Interestingly, zebrafish genomewide 
methylation levels are dynamk during development, and show similar trends to what is 
observed in mammals. Sperm is heavily methylated, while embryonic genome 
methylation levels are relatively hypomethylated through cleavage and early blastula 
stages. Genome methylation levels increase in late blastula stages, and show relatively 
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heavy methylation levels by gastrulation (Mhanni and McGowan 2004; Mackay et al. 
2007). 
1.9 Principal Hypothesis and Overall Objectives 
The principal hypothesis is that DNA methyltransferases function both together 
and independently with different factors to target and repress specific genes and 
constitutive heterochromatin that are necessarily silenced for development and cellular 
differentiation. The overall objectives are to (1) establish the zebrafish as a model for 
investigations of de novo DNA methylation, (2) determine the relevance of de novo DNA 
methyltransferases for different stages of normal development, and (3) present a precise 
compilation of the genes regulated by DNA methylation, providing insight into central 
developmental processes. 
1.10 Significance 
In combining the strengths of the zebrafish model with techniques capable of 
examining unexplored aspects of the de novo methyltransferases, this work provides new 
insight into the roles the dnmts play in controlling progression of the developing embryo 
through the various stages of development. Evidence suggests roles ranging from stages 
immediately following fertilization to terminal differentiation; by directly examining 
these processes in developing embryos, we have gained a more complete perspective for 
specific and overlapping contributions of the different dnmts. Characterizing the 
enzymes responsible for this epigenetic mechanism of gene control, as well as providing 
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genes that are either directly or indirectly regulated by methylation during development in 
zebrafish, a model rapidly gaining attention not only for normal development studies, but 
also for disease modeling and drug discovery (Langheinrich 2003), is highl y relevant 
given the potentially reversible nature of aberrant epigenetic marks, or epimutations 
(Brueckner and Lyko 2004). 
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Figure 1.1 Methylation of cytosine to 5-methylcytosine. Methylation in vertebrates 
typically takes place at CpG dinucleotides. Methyltransferase enzymes transfer a methyl 
group to cytosine from the methyl donor S-adenosyl-L-methionine (AdoMet or SAM) 
giving rise to 5-methylcytosine and S-adenosyl-L-homocysteine (SAH) (adapted from 
Qui, 2007). 
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Figure 1.2 Mechanisms of gene silencing by DNA methylation. DNA (black line) is 
coiled around histone proteins (light blue). Red circles represent methylated CpG sites. 
A) Methylation may prevent binding of a transcription factor when the methylated CpG 
lies within a recognition site. B) CpG methylation may recruit protein complexes (above 
the line) such as MeCP2 or MeCPl , that lead to the compaction of chromatin via 
modifications made to the histone tails, such as histone deacetylation, rendering the 
chromatin inaccessible to transcription machinery (adapted from Bird 2002) (MeCP = 
methyl CpG binding protein; MBD = methyl binding domain; HDAC = histone 
deacety 1 ase). 
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Figure 1.3 Schematic of the human DNA methyltransferases. Three fami lies are known; 
DNMTl, DNMT2, and DNMT3. These proteins, with the exception of DNMT2, possess 
an N-terntinal regulatory domain and a C-terminal catalytic domain. DNA 
methyltransferases contain up to ten conserved motifs which are indicated by Roman 
numerals. NLS, nuclear localization signal; RFT, replication foci-targeting domain; 
PWWP, a domain containing a conserved proline-tryptophan-tryptophan-proline motif; 
PHD, a cysteine-rich region containing a plant homeodomain (with permission from Chen 
and Riggs 2005). 
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Figure 1.4 A) Dnmtl preferentially methylates hemimethylated DNA and maintains the 
methylation pattern during DNA replication. B) Dnmt3a and Dnmt3b are capable of 
establishing methylation patterns in unmethylated DNA (Red methyl groups indicate 
newly added methylation events). 
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Figure 1.5 A) Schematic of mouse Dnmt3a and short isoform Dnmt3a2. Dnmt3a is more 
highly expressed in mammalian adult tissues while Dnmt3a2 is more highly expressed in 
embryonic development and targets euchromatin. B) Dnmt3b variants, several of which 
lack catalytic activity, are differentially expressed in development, and functional 
significance is unknown (adapted from Hermann et al. 2004). 
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Figure 1.6 The mechanism of DNA methylation involves DNMT binding to DNA, 
everting the cytosine to project out of the double helix (arrow) and following nucleophile 
attack on cytosine carbon 6, a methyl group is transferred from the methyl donor SAM to 
carbon 5, followed by release (adapted from Voet and Voet 2004). 
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Figure 1.7 Methylation dynamics in mamm alian development. The paternal genome 
(blue line) undergoes active demethylation following fertilization , while the maternal 
genome (red line) undergoes passive demethylation which is dependent on not 
maintaining methylation during DNA replication. At the blastocyst stage, a wave of de 
novo methylation occurs, though extraembryonic (EX) and embryonic (EM) lineages are 
methylated to different extents. Imprinted genes and some repeat sequences (dashed 
lines) maintain their methylation status throughout development (adapted from Reik et al. 
2001). 
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Figure 1.8 A) Female adult zebrafish in a 10 em culture dish with hundreds of newly 
fertilized embryos (adapted from Megason and Link 2007). B) Housing for zebrafish in 
circulating system. 
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Figure 1.9 Zebrafish embryogenesis. A) Schematic and live embryo images of 
developmental stages from the zygote period to the mid-segmentation period (fertilization 
to 19 hpf). The dorso-ventral axis may first be distinguished at shield stage (6 hpf). Cell 
movements in gastrulation stage embryos of epiboly (blue arrows), convergence (green 
arrows), and extension (red arrows) are in panel t. D, V, AP, VP, EVL, Ant., Pos., and hpf 
are dorsal, ventral, animal pole, vegetal pole, enveloping layer, anterior, posterior and 
hours post fertilization, respectively (adapted from Webb and Miller 2007 and from 
Schier and Talbot 2005). B) Camera Iucida drawing and live zebrafish image at 24 and 
36 hours post fertilization, repectively. Structures of greater relevance to this thesis are in 
bold (adapted from Schier and Talbot 2005; Dahm 2002). hg, nc, sc, and fp, are hatching 
gland, notochord, sclerotome, and floor plate, respectively. 
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Chapter 2: Novel Splice Variants Associated with One of the 
Zebrafish dnmt3 Genes 
A version of this chapter has been published in BMC Developmental Biology (Smith, 
T.H.L, Dueck, C.C., Mhanni, A.A. and McGowan, R.A. (2005). Novel splice variants 
associated with one of the zebrafish dnmt3 genes. BMC Developmental Biology 5(23)). 
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2.1 Introduction 
The epigenetic modification of DNA by the addition of a methyl group to the 5 
position of cytosine is an important mechanism for control of gene expre ion in 
vertebrate . Thi i particularly true during development where DNA methylation is 
thought to have a role in genome imprinting (Efstratiadis 1994; Reik and Allen 1994), X-
chromosome inactivation (Riggs and Pfeifer 1992) and lineage determination (Cedar 
1988). Methylation has been most inten ely studied in mammal where the level have 
been shown to be quite dynamic during early development, decreasing soon after 
ferti lization and increasing again by the gastrula stage (Monk et al 1987; Santo et a!. 
2002). The importance of this de-methylation/re-methylation cycle to the developmental 
process has been clearly demonstrated by perturbations of that methylation that generally 
leads to embryonic lethality (Li et al. 1992; Okano et al. 1999). Given the importance of 
methylation in ustaining normal early developmental proce se , the enzymes that add 
and maintain that methylation are of significant interest. The dnmt3 family of 
methyltransferases that are thought to be important in de novo methylation (that i the 
addition of methyl groups to previously unmethylated sequences) are of particular interest 
in this context. There are three members of this family in mammals; two have catalytic 
activity, Dnmt3a and Dnmt3b; and the third, Dnmt31, is important as a cofactor, 
particularly for the methylation of imprinted loci (Hata et al. 2002). Functionally, 
however, the dnmt3 family is not limited to just three product because both the Dmnt3a 
and Dnmt3b transcripts can be alternatively spliced to generate a number of different 
RNAs. Dnmt3a has two splice variant differing in the 5' region whereas Dnmt3b ha tx 
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identified splice variants (Chen et al. 2003). These variations in the Dnmt3 transcript and 
resulting proteins may allow for a greater diversity in the function and/or targets of the e 
enzymes. 
Methylation in zebrafish ha recently been the focus of a number of report , and 
methylation has been found to be dynamic during its early development (Mhanni et al. 
2004). Also, as in mammals, blocking re-methylation in zebrafish re ults in abnormal 
development and death (Martin et al. 1999). 
The zebrafish actually has at least twice the mammalian number of dnmt3 genes; IX 
have been submitted to databases o far (GenBank number AB196914, AB196915, 
AB196916, ABI96917, AB196918, AB196919) (Figure 2.1) (Shimoda et al. 2005). The 
higher number of genes in this gene family in teleosts is not urprising due to the genome 
duplication event early in the teleosts lineage (Postlewait et al. , 1998). The significance 
of the increa e in dnmt3 gene copy number in zebrafish is unknown. 
We have isolated and analysed a number of the zebrafi h dnmt3 gene sequences and 
have identified two dnmt3 sequences that are located very close together in a ingle 
linkage group and are therefore likely to be the result of a tandem gene duplication event. 
The very close proximity of the two equences provides an intere ting opportunity to 
examine how the expression of the e gene is controlled since one copy has a very limited 
upstream promoter region relative to the other. 
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2.2 Methods 
Total RNA was isolated from ovarian tissue using the phenol/chloroform method of 
Chomczynski and Sacchi (Chomczynski et al. 1987). Ovarian Poly A+ RNA (FastTrack 
2.0 kit, Invitrogen Inc. Carlsbad, CA) was used for first strand eDNA synthesis using the 
BD SMARTTM RACE eDNA Amplification Kit (Clontech, Palo Alto, CA) according to 
the Manufacturer's instructions. Using the zebrafish dnmt3 EST (GenBank number 
AF135438), a gene specific primer, GSPl (see Table 1 for primer sequences), was 
designed to amplify, along with the universal primer, the relevant eDNA using PCR 
conditions as described by the manufacturer. Based on a resulting sequence that 
corresponded to four different regions of the genomic map (The Sanger Institute 
Welcome Trust zebrafish sequencing project), a series of gene specific primers were 
designed for four different paralogues. 
PCR products were fractionated on 0.8% agarose gels, visualized with ethidium 
bromide, excised from the gel and cloned into pCR 2. 1 vectors (TOPO TA cloning kit, 
Invitrogen Inc. Carlsbad, CA). The cloned products were then purified (Wizard®Plus 
Minipreps, Promega Inc. Madison, WI), and sequenced (Cortec DNA Service 
Laboratories Inc., Kingston, ON). 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was used to 
determine the relative expression levels of gene 1 (dnmt3), gene 2 (dnmt5), and its 
variants in tissues. Total RNA from zebrafish ovarian tissue, 1-2 cell embryos, 64 cell 
embryos, 6 hour embryos, muscle tissue, and brain ti ssue was isolated as described above, 
and the integrity checked by ethidium bromide staining. The RNA was then reverse 
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transcribed usmg M-MLV Reverse Transcriptase (Invitrogen Inc. Carlsbad, CA) 
according to the manufacturer's instructions and using primers specific for the various 
genes and variants. GSP2 was used for first strand eDNA synthesis of Gene 1 in 
conjunction with GSP3, generating a predicted amplicon of 521 bp. Primer GSP4 
designed to anneal to all three gene 2 variants was used with GSP5 for dnmt3-2-l to 
produce a 420 bp amplicon and with GSP6 to produce two amplicons of 597 bp and 675 
bp from gene 2 variants dnmt3-2-2, and dnmt3-2b, respectively. In addition, RT-PCR was 
conducted to generate a 440 bp amplicon with GSP7 and GSP8, primers specific for a 
constitutively expressed transcript, max (Schreiber-Agus et al. 1994). PCR reactions 
were set up as described by the manufacturer, except that 2 ul of eDNA template were 
used for each reaction. PCR conditions were designed to ensure that all amplifications 
were within the logarithmic phase. Those conditions were: 94°C for 1 min, 25 cycles of 
(94°C 30 sec, 59°C for 30 sec, 72°C for 1 min), and a 72°C for 1 min final extension for 
all primer sets except max which was only amplified for 14 cycles. Controls lacking RT 
were run for each RNA sample. 
RT-PCR products were separated on a 1.5 % agarose gel, transferred to nylon 
membrane (Roche, Indianapolis, IN) and visualized by hybridization with a biotin labeled 
sequence designed to hybridize to gene I, gene 2, and the variants (North2South Biotin 
labeling kit, Pierce Biotechnology Inc. Rockford, ll). Densitometric analysis of 
autoradiographs was performed to determine the relative expression levels of the 
transcripts and their splice variants at the above mentioned zebrafish developmental 
stages and tissues. Samples could be compared on different blots by using a control 
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sample present on each autoradiograph, and samples were calibrated usmg the 
endogenous control max. 
Zebrafish care and feeding were performed essentially as described by Westerfield 
(Westerfield 1995). All experimentation was done with the approval of the Canadian 
Council on Animal Care. 
2.3 Results and Discussion 
We used a dnmt3 sequence already present in the zebrafish EST database (GenBank 
number AF135438) to identify and isolate the complete eDNA sequences of four of the 
dnmt3 genes found in the zebrafish. Three of these are located in the same linkage group 
(linkage group 23) and two of them very closely juxtaposed to each other (Figure 2.2). 
The very close proximity of those two genes has some interesting implications with 
respect to their origin and the control of their expression, given the much more limited 
potential promoter region of one relative to the other. We, therefore, undertook a closer 
examination of the two genes, which we named dnmt3-1 and dnmt3-2 . 
From the end of the polyA addition site of dnmt3-1 to the beginning of our cloned 
sequence for dnmt3-2 (probably not actually beginning at the cellular transcriptional start 
site) consists of only 1428 base pairs. Since there is only a small amount of 5' sequence 
that is associated with the dnmt3-2 gene this limits the control of the expression of this 
gene to a small and easily manipulated region. Analysis of this region suggests that it is a 
TATA-less promoter with a number of potential transcription factor binding sites 
including API and SPl binding sites, which have also been reported for mammalian 
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Dnmt3s (Yanagisawa et al. 2002; Detich and Szyf 2005). The sequence of the cloned 
genes, dnmt3-J and dnmt3-2, revealed open reading frames that could encode 
polypeptides of 1447 and 1297 amino acids, respectively. Comparison of the sequences of 
these two genes to zebrafish genomic maps present in the Genbank database allowed for 
an analysis of the genomic structure. That structure, along with the relative position of the 
two genes, is shown in Figure 2.2. The two genes are very similar in sequence; 72% 
identical at the nucleotide level and 74% identical at the amino acid level, with large 
regions being more than 80% identical (Figure 2.3). This is in contrast to only J 9- 28% 
identity at the nucleotide level, and 36-46% amino acid similarity when compared to the 
other dnmt3 sequences present in the zebrafish genome. This trend is also true for the 
conserved methyltransferase motifs. For instance, the PWWP motif of dnmt3-l and 
dnmt3-2 are 88% and 84% similar at the amino acid and nucleotide levels, respectively, 
but considerably less similar to the other dnmt3 sequences (e.g. dnmt3-2 vs. gene 4 
(dnmt7), accession #196918, has 64% and no significant similarity at the amino acid and 
nucleotide levels, respectively) (BLAST 2 Sequences, NCBI). 
Recent additions to the sequence databases included two zebrafish sequences that 
appear to correspond to the same two genes and were named dnmt3 and dnmt5 
respectively (GenBank numbers AB196914, and AB196916, respectively). Our 
sequencing data corroborate the sequences submitted to the databases except for a few 
minor variations in regions with triplet repeats which may be an artefact of polymerase 
slippage in cloning or represent real triplet repeat differences that exist in the gene. 
The high similarity between dnmt3-J (dnmt3) and dnmt3-2 (dnmt5) relative to other 
zebrafish dnmt3s, as well as their close proximity, suggests that these genes arose from a 
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duplication event. Postlethwait et al. (1998) provides support for a model where two 
polyploidization events occurred in a common ancestor of zebrafish and mammals. 
However, there are often additional multigene members in zebrafish. Postlethwait et al. 
( 1998) argues that either chromosome duplication or another tetraploidization event in the 
zebrafish lineage is the most likely mechanism by which these additional members arose. 
The tight clustering seen here, however, suggests that, at least in this instance, tandem 
gene duplication has occurred. 
The most interesting aspect of our analyses is that at least one of the genes, dnmtJ-2 
(dnmt5), includes at least two start sites and a number of splice variants. These were 
initially identified in eDNA libraries generated from 1-2 cell embryos and RACE-PCR 
and were later confirmed by RT-PCR in a number of early embryonic zebrafish stages as 
well as somatic tissues (Figure 2.4 ). This demonstrates that they are all expressed at least 
to the level of RNA. Densitometric analysis revealed that the transcript levels are not 
equivalent and that the relative levels of the different genes and isoforms fluctuate 
independently between the stages examined (Figure 2.5). All genes and variants 
examined are expressed in early embryonic stages, though dnmt-3-2-1 appears to be the 
most significant prior to zygotic gene activation (zygotic gene activation occurs at -3 
hours post fertilization). All transcripts demonstrated declining levels leading up to this 
event, suggesting maternal supply turnover. Following zygotic gene activation, however, 
there appears to be a marked shift towards dnmtJ-1 being the most highly expressed. 
Additionally, there appears to be tissue dependent differences in transcript expression 
levels (Figure 2.5 B). These differences in expression profiles for the different transcripts 
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and splice variants suggest that they are regulated independently and each may be playing 
distinct and separate roles during the development of the zebrafish. 
The shortest of these variants, dnmt3-2-1, corresponds to the dnmt5 sequence in the 
database. The two novel variants reported here differ in size from that sequence by 187 
(dnmt3-2-2) and 265 (dnmt3 -2-2b) base pairs. These variants are actually associated with 
the gene having the most restricted promoter region. A schematic of the three products is 
shown in Figure 2.6. 
There are several interesting aspects of these dnmt3-2 (dnmt5) variants. To begin 
with, although the splicing difference between variant dnmt3-2-2 and dnmt3-2-2b appears 
to involve the same 3' splice junction, it has a different 5' splice junction, meaning that 
one of those splice sites is located within the exon of the other variant. However, both of 
the junctions still abide by the GT/AG rule for splice junctions. 
The second interesting aspect of these splice variants is that all of them are 5' to the 
initiator AUG. Therefore, none of them actually affect the amino acid sequence. This 
suggests that either the splicing differences are trivial or they play a regulatory role in the 
translation or localization or some other aspect of the expression of various splice 
variants. The latter possibility is a more reasonable assumption since, parsimoniously, it 
seems unlikely to assume that this RNA would be alternatively spliced in a variety of 
ways for no biologically relevant reason. This situation is not unique to zebrafish dnmt3 
genes. Similar splice variants in the 5' untranslated region have also been reported for 
human DNMT3s, though the significance of these variants is not known (Yanagisawa et 
al. 2002). 
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2.4 Conclusion 
We have isolated and analysed several of the dnmt3 genes from the zebrafish. In 
this report we have focused on two of the genes that are located in close proximity in a 
single linkage group and we find that the two genes are considerably more simjJar to each 
other than they are to the other zebrafish dnmt3 genes. This suggests that they arose as a 
result of a relatively recent gene duplication event. We have also found evidence for the 
existence of several different splice variants and alternative splice si tes associated with 
one of the two genes, remjniscent of what is seen with the human DNMT3s. Expression 
analyses of these genes and variants demonstrate they are dynamjc during development 
with distinct patterns that suggest they are independently controlled and, possibly, have 
different functions in development. 
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Figure 2.1 The de novo methyltransferase family in zebrafish. A) Schematic of zebrafish 
dnmt3 proteins. B) Radial Tree showing relationships between amino acid sequence of 
zebrafish DNA methyltransferases and mouse Dnmt3a and Dnmt3b (also in Shimoda et 
al. 2005). 
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Figure 2.2 The dnmt3 genes in zebrafish. A) The Welcome Trust Sanger Institute library 
numbers are provided for all genes while the genomic size and distances are indicated for 
genes 1, 2, and 3. B) A more detailed view of the genomic structures of Gene 1 (dnmt3) 
and Gene 2 (dnmt5). Boxes represent exons and adjoining lines represent introns. 
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dnmt3-1 
dnmt3-2 
Figure 2.3 Homology between Gene 1 (dnmt3) and Gene 2 (dnmt5) at the nucleotide 
level. Percentages above 80% are shaded, and specific homology percentages are 
provided below the figure (numbers obtained by BLAST alignment, NCBI). Arrows span 
the nucleotides that give rise to the identified motifs labelled above the respective arrows. 
Note: All identified motifs are characteri stic of the C-5 methyltransferases, with the 
exception of the CH domain. 
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Figure 2.4 dnmt3 isoforms. A) RT-PCR followed by agarose gel electrophoresis and 
hybridization with a biotin-labelled probe. Stages/tissues used are labelled on the left side 
of figure. The first lane in all cases contains a doublet representing the two splice variants 
of dnmt3-2 differing in size by 78 bp. The second lane shows the alternate translational 
start site variant of dnmt3-2. The third lane is the product of the primers specific for gene 
1 and the last lane is a control reaction loaded on each gel to allow comparisons between 
gels. The amount of reaction loaded was not the same in all lanes but was varied to 
produce more equivalent band intensities for more accurate quantification. Controls 
lacking reverse transcriptions produced no amplification products (not shown). B) RT-
PCR of a constitutively expressed gene, max, was performed for each RNA used serving 
as an internal standard for quantification. Lanes 1- 6 show the m.ax amplicons generated 
from the samples used in panel (A), ovaries through to brain. Lane 7 contains size 
markers. 
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Figure 2.5 Expression summary. A) Graph showing data from Figure 2.4 developmental 
stages corrected for differences in amounts loaded, and normalized to max to correct for 
concentration differences as well as the control for exposure differences (see methods). 
B) Graph showing data from Figure 2.4 somatic tissues corrected as above and 
demonstrating the relative expression levels of the three transcripts in those tissues. 
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Figure 2.6 The vartous transcripts produced from Gene 2 (dnmt5). The genomic 
structure is presented on the top line, with the 5' region of interest magnified below 
illustrating the various alternative splicing products. Splice variant dnmt3-2-l differs 
from the others by an alternate transcriptional start site and a missing exon 2. Transcripts 
dnmt3-2-2 and dnmt3-2-2b lack the first exon and are alternatively spliced in the second 
exon (the one missing from transcript 1). All splice variants occur upstream of the AUG 
start site (Red box= exonl, blue and orange box= exon2). 
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Table 2.1 Primers used. 
Primer name 
GSPI 
GSP2 
GSP3 
GSP4 
GSP5 
GSP6 
Sequence 
5'- GACAGGACCCTGAA TGGACGTCGCT 
5'- GAGAGAGCACTGAGATGTCAG 
5'- CCAGAAA TCTGTTGGAGACA TT ACACC 
5'-AAGGCAGT ATGGAGTCTGTCTGCA 
5'-CAGTCA TGGCAA TGTCTTTCC 
5'-A TGT A TGTCCTGTGAGGAGGAAC 
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Chapter 3: Expression of de novo DNA Methyltransferases in 
Zebrafish Development 
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3.1 Introduction 
In eukaryotes, the addition of a methyl group to the 5 position of cytosine found in 
CpG dinucleotides is catalyzed by the DNA methyltransferase (Dnmt) proteins (Brero et 
al. 2006). In mammals, the Dnmts are comprised of Dnmtl, Dnmt2, Dnmt3a, Dnmt3b, 
and Dnmt31. However, the activities of the enzymes are divided into distinct families, 
where Dnmtl is important for the maintenance of methylation patterns during DNA 
replication, while the Dnmt3 family of proteins are referred to as the de novo 
methyltransferases due to their ability to establish the methylation pattern on DNA during 
development (Brero et al. 2006). Dnmt2, unlike the others, may not be relevant to DNA 
methylation but rather to RNA methylation instead (Rai et al. 2007). 
DNA methylation is a repressive mark that has been implicated in cell 
differentiation (Li et al. 2007), modulating tissue-specific gene expression (Oka et al. 
2005; Rai et al. 2006), genomic imprinting (Kaneda et al. 2004), X-chromosome 
inactivation (Barr et al. 2007), silencing of endogenous parasitic elements (Walsh et al. 
1998), cancer (Esteller et al. 2001), learning and memory, and mental health disorders 
(Mill et al. 2008). DNA methylation is not universal to all animals, though it appears to 
be essential for proper development in those that do employ this mechanism of gene 
control (Suzuki and Bird 2008). For instance, and for reasons sti ll under investigation, 
Dn.mt3b and Dn.mt3a null mice demonstrate either pre- or early post-natal lethality, 
respectively (Okano et al. 1999; Suzuki and Bird 2008). Although the relevance of DNA 
methylation to the development of zebrafi sh, a non-mammalian vertebrate, has been 
debated in the past, mounting evidence indicates that in fact, as in other animals which 
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methylate, it is very relevant and likely even essential (Martin et al. 1999; Smith et al. 
2005; Rai et al. 2006; Mackay et al. 2007). 
There are several questions concerning methylation that remain unresolved. These 
include, but are not limited to, understanding the precise role(s) of each of the Dnmts in 
development as well as in the above mentioned processes, and uncovering what it is that 
enables the Dnmts to target particular DNA sequences, given the apparent lack of 
sequence preference beyond CpG dinucleotides (Chen and Li 2006). 
Study of DNA methylation during development highlights a particularly intriguing 
phenomenon, as methylation levels are highly dynamic during the early stages (Morgan et 
al. 2005). Traditionally, mammals, and in particular, mice, have been the favoured 
models for methylation studies. However, in these animals the embryos are least 
accessible when many of these changes are occurring. Zebrafish on the other hand, have 
been well established as an excellent model system for developmental studies given their 
external fertilization, optically clear embryos, and rapid ontogeny (Link and Megason 
2008). 
In addition to being an excellent developmental model for organogenesis, zebrafish 
demonstrate significant potential for investigations of DNA methylation. We and others 
have shown that several aspects of zebrafish methylation are in keeping with mammals. 
For instance, the dynamic changes in methylation that are seen during the course of 
mammalian embryonic development have also been evidenced in zebrafish embryos 
(Mhanni and McGowan 2004; Mackay et al. 2007). Additionally, the pattern of 
methylation in zebrafish is described, as in mammals, as global methylation (Suzuki and 
Bird 2008). Here, DNA methylation is located throughout the genome and punctuated 
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with short unmethylated regions termed CpG islands. This is in contrast to many plant , 
fungi, and some invertebrates, where methylation patterns have a fractional organization 
and are said to be mosaic, with heavily methylated and unmethylated domains. The 
functional utilization of DNA methylation also appears to differ between these systems 
(Brero et al. 2006; Suzuki and Bird 2008). 
Another attribute of zebrafish that may help in gaining an understanding of the role 
of methylation during development is that zebrafish, unlike mammals, do not have 
imprinted genes (Yokornine et al. 2006). Zebrafish do not have an identified Dnmt31, 
which acts as a co-factor to Dnmt3a in methylating mammalian imprinted genes. Thi is 
not a surprise as the attainment of a Dnmt31 gene in a common ancestor of mammal 
through gene duplication has been suggested to potentially be a critical event in the 
evolution of imprinting (Yokomine et al. 2006). However the lack of the confounding 
factors of dnmt31 and imprinting in zebrafish may facilitate teasing out the function(s) of 
the various dnmts in development. This is particularly true for Dnmt3a because it will 
allow us to identify its role in development, beyond its role in imprinting. 
All of the dnmt genes have been isolated from the zebrafish and one difference 
between them and mammals is in the number of dnmt3 genes. Specifically, six different 
dnmt3 genes have been identified in zebrafish, along with splice variants for dnmt5 
(Shimoda et al. 2005; Smith et al. 2005). It is not unusual, however, to observe multiple 
paralogues in zebrafish relative to mammals. There are numerous examples in zebrafish 
where this is the case, and the observed redundancy is a result of a genome duplication 
event during the evolution of teleo ts estimated to have occurred approximately 450 
million years ago (Postlewait et al., 1998). Sequence analysis of the six zebrafish de novo 
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methyltransferase genes suggests that four of the six (dnmt3, dnmt4, dnmt5, dnmt7) are 
more closely related to DNMT3B (amino acid identity 50%-67%), while two of the 
zebrafish dnmts are more similar to DNMT3A (dnmt6 and dnmt8) (amino acid identity 
81 % and 76%, respectively). Interestingly, and in keeping here, Dnmt3a has been more 
highly conserved in vertebrate evolution, while Dnmt3b is more divergent. Likely, 
Dnmt3a serves a fundamental role in vertebrate development, and in placental animals 
was co-opted for imprinting (Yokomine et al. 2006). We have previously suggested that 
dnmt3 and dnmt5 represent a relatively recent tandem gene duplication event (Smith et al. 
2005). 
Here we exarrune the transcript expression of the zebrafish de novo 
methyltransferases during development, and in adult muscle and brain ti ssues. Both 
semi-quantitative RT-PCR with templates from eight developmental stages and in situ 
hybridization analysis of two developmental stages have been carried out in order to 
examine the transcriptional control of the dnmt3 genes. By characterizing the transcript 
expression of these genes we are able to begin identifying the stages in development and 
the different tissues where the various dnmts may be more functionally relevant. 
3.2 Methods 
Reverse transcription-polymerase chain reaction (RT-PCR) was used to determine 
the relative transcript expression levels of zebrafish genes dnmt3 (Genbank accession # 
AB 196914), dnmt4 (Genbank accession # AB196915), dnmt6 (Genbank accession # 
AB196917), dnmt7 (Genbank accession # AB196918) and dnmt8 (Genbank accession# 
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AB196919). Total RNA was isolated from adult zebrafish ovarian, muscle, and brain 
tissues, and seven developmental stages spanning 1-2 cell to 72 hour stage embryos. 
Total RNA was isolated using the phenol/chloroform method of Chomczynski and Sacchi 
(Chomczynski et al. 1987). The RNA was reverse transcribed with M-MLV Reverse 
Transcriptase (Invitrogen Inc. Carlsbad, CA) according to the maufacturer's instructions 
and with 1 ug RNA. PCR was carried out using primers specific for the various genes 
(Table 1) and that spanned more than one exon to determine genomic contamination. In 
addition, RT -PCR was conducted to generate a 440bp amp Iicon with primers specific for 
a constitutively expressed gene, max (Schreiber-Agus et al. 1994). PCR conditions were 
designed to ensure that all amplifications were within the logarithmic phase. Those 
conditions were; 94°C for 1 min, 26-28 cycles of 94°C 30 sec (cycle number was gene 
dependent and max was amplified for 16 cycles), 59°C for 30 sec, 72°C for I min, and a 
72°C for 1 min final extension for all primer sets. Each developmental stage sample 
consisted of a minimum of 400 embryos, and three independent samples were collected 
and analysed for expression per developmental stage. Muscle, brain, and ovary samples 
were dissected from adult fish and were performed in triplicate. The same proportion of 
of PCR product was run on agarose gels for each stage or tissue examined (From 50 ul 
PCR product, 24 ul target gene PCR product, and 12 ul max PCR product was loaded for 
agarose gel electrophoresis). No RT controls were carried out alongside each reaction. 
RT-PCR products were separated by electrophoresis on a 0.8% agarose gel and 
visualized by SYBR Green staining (Roche Mississauga, ON). Densitometric analysis 
(Scion image, NIH) of gels using mean pixel intensities was performed to determine the 
relative expression levels of the transcripts for the zebrafish developmental stages and 
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tissues examined. Samples were normalized usmg the endogenous control max by 
determining the ratio of max/target gene ratio of the densitometric analysis (Schreiber-
Agus et al. 1994). 
Embryo fixation and DIG-labelled in situ hybridization were performed as 
described by Thisse and Thisse (2007). The antisense and sense probes for the zebrafish 
dnmts correspond to the following nucleotides: dnmt3 & dnmt5, 864 nt (AB196914 
nucleotides 1028-1891 ; probe 100% match to dnmt3, 98% match to dnmt5); dnmt7, 896 
nt (AB196918 nucleotides 5039-5934), dnmt6 & dnmt8, 715 nt (ABl96917 nucleotides 
1 71 3-2427; probe 100% match to dnmt6, 79% match to dnmt8). Probes were also 
designed to more specifically target dnmt3 alone and dnmt6 alone, though results were 
similar to those obtained from the dnmt3 & dnmt5, and dnmt6 & dnmt8 probes. 
Zebrafish care and feeding were performed essentially as described by Westerfield 
(Westerfield 2000). All experimentation was done with the approval of the Canadian 
Council on Animal Care. 
3.3 Results and Discussion 
RT-PCR revealed that zebrafish dnmt transcript levels are dynamic during 
development and that they demonstrate tissue specificity (Figure 3.1 and Figure 3.2). The 
presence of transcripts in early cleavage stages in all cases presumably represents a 
maternal supply of dnmt RNA and the general decrease in transcript levels that is seen 
prior to zygotic gene activation is suggestive of maternal supply turnover (Figure 3.2). 
This is followed by an up-regulation shortly after the mid-blastula transition (MBT) stage 
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which occurs just prior to three hours post-fertilization during zebrafish development 
when raised at 28.5 °C. Interestingly, general trends of transcript expression following 
the MBT divide the genes into two groups, and these groupings also are in keeping with 
genes most similar to mammalian Dnmt3b and those most similar to mammalian Dnmt3a. 
dnmt3, dnmt4, dnmt5 (not shown here, but previously reported; Smith et al. 2005), and 
dnmt7 demonstrate a more pronounced increase in transcript expression around 6 hpf of 
development, decline by 24 hpf, and are no longer detectable, at this PCR cycle number, 
by 72 hpf (Figure 3.2). This is in contrast to dnmt6 and dnmt8, which demonstrate early 
expression with up-regulation following the MBT continuing through to at least 72 hpf 
(Figure 3.2). 
In addition to the difference in regulation seen following 6 hpf between the 
zebrafish genes homologous to Dnmt3b, and those homologous to Dnmt3a, the former 
genes were not as highly expressed in adult zebrafish muscle and brain as levels shown 
during embryogenesis. Conversely, dnmt6 and dnmt8 demonstrate equal or higher levels 
of transcript expression in the adult brain relative to their developmental regulation 
(Figure 3.2). 
In situ analysis at 24 hours provides information on the tissue specific regulation of 
these genes during development. One region of shared expression among the de novo 
dnmts during development at 24 hours is in the optic tectum (Figure 3.3). This structure 
in non-mammalian vertebrates is the major visual processing center of the brain, and 
interestingly, zebrafish are capable of retinotectal regeneration (Bilotta and Saszik 2001). 
Transcripts corresponding to the de novo dnmt genes are certainly expressed in the 
head region and brain more so than caudally during zebrafish development and, with 
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exception of dnmt6, dnmt8, and dnmt4, de novo dnmt expression appears to be limited to 
this region. At 24 hours, dnmt3 and dnmt5 are expressed in the telencephalon, 
diencephalon, hindbrain, eye, and brachial arches (Figure 3.3). dnmt7 on the other hand 
appears to be most strongly expressed in the optic tectum and tegmentum (Figure 3.3). 
dnmt6 and dnmt8 demonstrate a more ubiquitous expression throughout the embryo 
(Figure 3.3). Expression of dnmt6 and dnmt8 appears less intense in the notochord, 
however, at 24 hpf this tissue becomes progressively less penetrable to RNA probes for 
whole-mount in situ hybridization (Thisse and Thisse 2007) and may not be indicative of 
a decrease in expression. dnmt4 at 24 hours shows a punctuated expression along the 
aorta wall as well as its expression in the eye and brain (midbrain, rhombomere 4) 
(published elsewhere Thisse and Thisse 2004). 
Although it is important to realize zebrafish whole-mount in situ analyses beyond 
48 hpf are no longer indicative of expression in the trunk and tail due to lack of RNA 
probe penetration (Thisse and Thisse 2007), in situ results at 72 hours corroborate RT-
PCR findings with negligible expression of dnmt3, 5, and dnmt7 (Figure 3.4) in tissues 
previously demonstrating expression and that are penetrable at this stage. dnmt4 also 
shows declining expression, and by the long-pectoral stage expression is limited to the 
retina proliferative zone, posterior tectum, brain ventricular zone, and branchial arches 
(Thisse and Thisse 2004). dnmt4 expression beyond 48 hours of development was not 
determined. In situ background levels at 72 hours (multiple probes tested) against dnmt6 
and dnmt8 prevent conclusions regarding tissue specific expression at this time point 
(Figure 3.4), though RT-PCR findings suggest relatively higher levels of expression than 
at 24 hours for dnmt6, and at least equal levels of expression for dnmt8 (Figure 3.2). 
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Overall, the differences in in situ expression of the de novo dnmts in one to three 
day embryos demonstrates that these genes are regulated independently and may, 
therefore, be playing distinct roles during development of the zebrafish. 
De novo dnmt expression in zebrafish shows some strong similarities to the 
expression of the Dnmt3s in mammals. Generally, in mammals, Dnmt3a and Dnmt3b are 
expressed in ES cells, early embryos and developing germs cells, and are downregulated 
in somatic tissues of postnatal animals (Okano et al. 1999). In the central nervous 
system, however, recent evidence indicates an initial overlapping expression of Dnmt3b 
and Dnmt3a during early neurogenesis (Ell.5-El5.5), after which Dnmt3b becomes 
undetectable (Feng et al. 2005). Dnmt3a on the other hand, becomes significantly 
increased in expression levels postnatally, reaching peak levels during the first three 
postnatal weeks, and decreasing again by adulthood. This peak in expression corresponds 
to timing of neural maturation in mice. The authors conclude that both Dnmt3a and 
Dnmt3b are likely important during early neurogenesis, but Dnmt3a probably has a role 
in CNS maturation and postnatal function (Feng et al. 2005). Interestingly, in zebrafish, 
neuronal maturation is occurring between 24-72 hpf (Detrich et al. 1999), a time period 
where we demonstrate dnmt6 and dnmt8 expression is relatively high. 
3.4 Conclusion 
This study demonstrates that the de novo methyltransferases in zebrafish display 
dynamic expression patterns during development, and exhibit some similarities to general 
expression patterns in mammalian development. All transcripts are likely maternally 
64 
supplied. The genes most similar to Dnmt3b are relatively less expressed following 
somitogenesis, while genes most similar to Dnmt3a are relatively highly expressed 
through organogeneis and neurogenesis stages. Additionally, these latter genes are 
relatively prevalent in adult tissues examined. Overlapping, as well as tissue specific 
expression was demonstrated by in situ analysis, suggesting the de novo dnmts may have 
some redundancy, or interaction dependent roles in development, as well as non-
overlapping specificities. 
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Figure 3.1 dnmt3 gene expression determined by A) RT-PCR, followed by gel 
electrophoresis, SYBR staining, and B) densitometric analysis. Shown here, sample data 
of dnmt6 and dnmt8 alongside ubiquitously expressed control gene max in 64 cell stage 
embryos, 24 hour embryos, and adult brain tissue. 
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Figure 3.2 Relative expression levels of dnmt3 genes during zebrafish embryonic 
development and in adult tissues. Expression data represent the average expression ±SD 
determined from three biological replicates. In the case of developmental stages, samples 
consist of a minimum of 400 embryos collected per sample. General trends of expression 
divide the genes into two groups. A) dnmt3B-like genes that demonstrate increased 
expression at 6 hours development, and no longer detectable at this PCR cycle number by 
72 hours and relatively low levels in muscle and brain B) dnmt3A-like genes that present 
equal or increasing expression through to 72 hours of development, and relatively high 
levels of expression in adult muscle and brain. 
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Figure 3.3 Analysis of dnmt expression by whole mount in situ hybridization at 24 hours 
development. Panels on the left are hybridized with antisense riboprobes, and panels on 
the right are hybridized with sense control riboprobes. A) probe designed against dnmt3 
& dnmt5 demonstrates expression in the fore-, mid-, and hindbrain. B) dnmt6 and dnmt8 
demonstrate expression more ubiquitously, though some background is present in sense 
control embryos. C) dnmt7 is expressed in the optic tectum and tegmentum. 
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Figure 3.4 Analysis of dnmt expression by whole mount in situ hybridization at 72 hours 
development. Tail and trunk tissues are impenetrable to RNA probes at this stage. Panels 
on the left are hybridized with antisense riboprobes, and panels on the right are 
hybridized with sense control riboprobes. A) probe designed against dnmt3 & dnmt5 
indicates expression levels undetectable. B) dnmt6 and dnmt8 background levels in sense 
control embryos at 72 hours make determining expression by in situ difficul t despite 
attempting the use of several different probes. C) low expression of dnmt7 is detected in 
the optic tectum. 
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Table 3.1 RT-PCR primers employed to generate gene specific amplicons. 
Primer Name Sequence (5'- 3') Amplicon size 
dnmt3F ATGGACATCATTCAACCTGG 543 bp dnmt3R AAGGCAGTATGGAGTCTGTCTGCA 
dnmt4F CTCCACTACTGAAACAGCCAGTC 587 bp dnmt4R GTTCTCTGCTGTAGACCTCCTCA 
dnmt6F AGAGCAGGCAAAACCTTCC 553 bp dnmt6R CCAACAAATCCACACACTCC 
dnmt7F TGCAATCCTGTGATGATTGATGC 382 bp dnmt7R AGAGATGTCGGATCACAGGAACG 
dnmt8F CACGTATGTTGGAGACATCAGG 595 bp dnmt8R GTTGGACACGTCAGTGTAATGG 
maxF GCCGAAGAATGAGCGACAACG 440 bp 
maxR GCTTGTCCCTTGGGGTTGGTG 
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Chapter 4: Knockdown of Zebrafish de novo DNA 
Methyltransferases 
75 
4.1 Introduction 
Many inroads to understanding DNA methyltransferases and their function in 
development are being made through the use of morpholino antisense oligonucleotide 
(MO) injections into zebrafish embryos. This reverse genetic approach allows for the 
study of particular genes of interest during early development. MOs are small ( -25 base 
pairs) synthetic DNA analogues containing a 6-membered morpholine ring instead of a 
deoxyribose moiety; they have a neutral charge backbone, and are resistant to nuclease 
cleavage (Chen and Ekker 2004). The conserved spacing and similar base-stacking 
ability of MOs as compared to natural genetic material allows the MO to undergo 
complementary base pairing to the transcript of interest and inhibit its function (Figure 
4.1) (Nasevisius and Ekker 2000). 
Based on design, two different types of MO are commercially available 
(GeneTools, LLC), and disrupt gene function in one of two ways (Figure 4.2). The first 
type of MO acts as a translation blocker and may be targeted to sequence located between 
the 5'cap and the first 25 bases 3 'of the translation initiation codon (Chen and Ekker 
2004). The presence of the start site blocking MO sterically hinders the binding of the 
translation machinery, resulting in knockdown of the protein of interest. Given the 
mRNA level of the target gene is unaffected, efficacy of knockdown may be assessed by 
western blotting provided appropriate antibodies are available (Chen and Ekker 2004). 
The second type of MOs, splice-site targeting MOs, target exon-intron junctions, 
sterically hinder the splicing apparatus, and may effectively cause either an exon to be 
skipped and excluded or an intron to be included (Figures 4.2 and 4.3) (Ekker and Larson 
76 
2001). The concentration of MO injected may need to be higher for this type of MO 
relative to translation blocking MOs due to the narrow window during which nuclear 
processing events take place, and therefore the brief time period where they may be 
effective (Malicki et al. 2002). As MO interference results in aberrantly spliced 
transcripts, the efficacy of the knockdown may be assessed by designing primers flanking 
the splicing event. The presence of an aberrant transcript may be determined by RT-PCR, 
clearly an important advantage as it removes the need for appropriate antibodies (Figure 
4.3) (Chen and Ekker 2004). However, maternally provided transcripts will remain 
unaffected as they are already processed. 
One of the major advantages of zebrafish over other models of development is that 
zebrafish embryos are particularly amenable to reverse genetic approaches (Link and 
Megason 2008). Large numbers of embryos may be collected (typical pairing may 
provide 50-250 eggs) and up to a thousand embryos may be injected in a matter of hours. 
Injections are performed using a pressure injector, micromanipulator, and a dissecting 
microscope (Figure 4.4). Preferably, injections are performed on 1-cell stage embryos to 
ensure even distribution of the morpholino; however, zebrafish embryos are meroblastic 
during early development, allowing for reagent transfer between cells until the 16-cell 
stage (Link and Megason 2008). Embryos are then allowed to develop normally, and 
may be monitored for phenotypes resulting from the knockdown (Figure 4.4). As 
morpholinos may not result in complete loss of expression, the term "knockdown" is used 
rather than "knockout," and embryos with a phenotype are referred to a "morphants" 
rather than "mutants" (Link and Megason 2008). Of course, monitoring for morphants is 
made possible by the transparent nature and rapid ontogeny of zebrafish embryos and 
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further molecular analysis of the knockdown and its effects may be easily pursued as 
embryos with or without phenotype may be collected, in situ hybridizations may be 
performed, protein may be extracted for western blots etc., or nucleic acids may be 
extracted for a number of analyses, such as Northern blots, RT-PCR, and bisulfite 
sequencmg. 
A precaution that needs to be considered when designing and performing zebrafish 
MO experiments is that, despite relatively low toxicity compared to other reverse genetic 
technologies, non-specific off-target effects do occur with 15-20% of MOs used in 
zebrafish (Urtishak et al. 2003; Robu et al. 2007). Non-specific effects include neural 
death that peaks at I day post-fertilization, and embryos having smaller heads and eyes 
and exhibiting somite and notochord abnormalities, as well as demonstrating craniofacial 
defects later in development (Robu et al. 2007). The cause of these effects is p53-
induced apoptosis; interestingly, they may be alleviated with injection of p53-targeted 
MOs. One approach that is proving quite effective is to co-inject a p53 MO with MOs 
that result in off-target effects, allowing resolution of specific loss of function phenotypes 
(Robu et al. 2007). 
In addition to the above mentioned "morpholino" phenotype that needs to be 
monitored, Ekker and Larson (2001) highlight four scenarios that need to be considered 
when injecting morpholinos, underlining the critical necessity for proper controls. The 
first scenario is desired affect which is the specific loss of function effects against the 
gene of interest. Secondly, and actually the most common result when researching a 
novel gene, is no phenotype and no mis-targeting. Thirdly, specific loss of function effect 
against the gene of interest may occur, however this may be accompanied with a mis-
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targeting phenotype. Lastly, the MO injection may result only m a mis-targeting 
phenotype (Ekker and Larson 2001). 
In order to determine if any of the above are occurring, several different controls are 
necessary. A MO with reduced efficiency, due to 4 or 5 base pair mismatches to the 
experimental MO, will provide insight into any non-specific toxicity (Pickart et al. 
2004). A more robust control to demonstrate MO specificity is to rescue the phenotype 
by co-injection of an mRNA that does not contain the MO target sequence. For example, 
with a translation blocking MO, the target sequence may be modified so as to not bind the 
MO while maintaining a KOZAC sequence, or in zebrafish the mammalian orthologue 
mRNA may be injected. This method is often limited by the fact that the temporal or 
spatial control of expression may be inappropriate, resulting in lack of rescue (Link and 
Megason 2008). Another approach is to phenocopy the first MO injections by injecting a 
second MO with non-overlapping sequence to the first. Likely the best approach in all 
cases to demonstrate specificity is to simultaneously target the same mRNA with two 
non-overlapping sequences. This synergy allows for each of the MOs to be injected at 
doses lower than when injected independently, thus decreasing the incidence of mis-
targeting and non-specific effects (Pickart et al. 2004). 
To date, MOs against dnmtl (Rai et al. 2006), dnmt2 (Rai et al. 2007), and all of the 
de novo methyltransferases (Shimoda et al. 2005), have been injected into developing 
zebrafish embryos. In several instances insight has been gained into the function of 
methyltransferases in development, and, in two of these instances, they have been linked 
with terminal differentiation. 
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In a study examjning the interplay between dnmtl and a histone methyltransferase 
suv39hl, it was determined that terminal differentiation of the intestine, exocrine 
pancreas, and retina were impaired upon dnmtl MO injection, and partially restored with 
suv39hl overexpression (Rai et al. 2006). The authors concluded these epigenetic 
modifiers function in the same pathway. In the future, it will be very interesting to 
discover the specific genes that are under the control of the methyltransferases to result in 
this disrupted differentiation. 
Until recently, the function of dnmt2 remained somewhat of an emgma. Mice 
lacking Dnmt2 demonstrated no developmental phenotype, nor did they provide evidence 
of any changes in overall genomic DNA methylation levels (Goll and Bestor 2005), while 
overexpression in Drosophila melanogaster resulted in an increase in DNA methylation 
levels, though not necessarily at CpG sites (Kunert et al. 2003). Again, however, 
omission of Dnmt2 in flies, did not result in any developmental abnormalities (Kunert et 
al. 2003). Finally, Dnmt2 is the most conserved of the methyltransferases, being present 
in lower eukaryotes such as Schizosaccahromyces pombe, which Jacks Dnmtl and Dnmt3 
(Goll and Bestor 2005). Overall, there appears to be both support for and against Dnmt2 
as a DNA methyltransferase (Rai et al. 2007). Zebrafish MO injections have helped 
provide insight into the controversy surrounding dnmt2 function. In a series of 
experiments with dnmt2 knockdown followed by rescue experiments with dnmt2 mRNA 
that could only localize to the nucleus or the cytoplasm, Rai et al. (2007) demonstrated 
that proper terminal differentiation of the liver, retina, and brain was dependent on dnmt2 
activity in the cytoplasm, but not the nucleus. This group further provided support that 
the RNA species targeted by dnmt2 was in fact tRNA (Rai et al. 2007). 
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Previously, zebrafish de novo DNA methyltransferases have been knocked down by 
MO injection (Shimada et al. 2005). However, this study was focused on determining the 
methyltransferase responsible for methylating the no tail (ntl) gene during development. 
Shimada et al. (2005) successfully demonstrated that following dnmt7 MO injection, the 
CpG island of ntl, which normally displays methylation at nearly half of the CpG 
dinucleotides by 48 hpf in zebrafish, showed decreased levels of methylation to 20% of 
normal. This was the first demonstration of a de novo methyltransferase gene being 
directly implicated in gene-specific methylation during development. Interestingly, 
overall genomic DNA methylation levels remained unchanged. Most notably, no 
phenotype was associated with the disrupted methylation of ntl, though complete 
knockdown was not achieved, and some methylation remained at the ntl CpG island 
(Shimada et al. 2005). In fact, no phenotypes were reported following MO injections 
against any of the de novo dnmts (Shimada et al. 2005). 
Given the likelihood that the increased number of dnmt3s in zebrafish respective to 
mammals is a result of gene duplication, there may in fact be considerable redundancy in 
function among these proteins, and so we continued with our investigations, despite the 
report of lack of phenotype following de novo methyl transferase targeted MO injection. 
To address questions regarding the role of the de novo DNA methyltransferases in 
vertebrate development, we injected MOs into 1-8 cell stage zebrafish embryos to 
knockdown expression of dnmt3, dnmt5, dnmt6, dnmt7, and dnmt8 individually, followed 
by co-injections based on gene homology to each other, and in groupings based on 
homology to mammalian Dnmt3a and Dnmt3b. Co-injections therefore consisted of: 
dnmt3 and dnmt5 MOs; dnmt3, dnmt5, and dnmt7 MOs; dnmt6 and dnmt8 MOs. 
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Injections against dnmt4 will also be included once a working set of MOs has been 
obtained for the above mentioned genes, details to follow. 
4.2 Methods 
Wild type zebrafish were raised at 28°C by using standard methods (Westerfield 
2000). Following injections, embryos were raised in Petri dishes containing embryo 
medium (Westerfield 2000) and were monitored for phenotype. Post-fertilization 
unfertilized embryos were removed from dishes between 4 and 6 hours. 
Morpholino antisense oligonucleotides (MOs) were designed by and purchased 
from Gene-Tools LLC (Philomath, OR). MOs were dissolved to a stock concentration of 
lmM and diluted with Danieau (58 mM NaCI, 0.7 mM KCl, 0.4 mM MgS04, 0.6 mM 
Ca(N03)2, 5.0 mM HEPES pH 7.6) prior to injection. Initial injections also included 
phenol red (final concentration 0.2%) for visualization. Unless stated otherwise, a 
minimum of 50 embryos were employed per injection dose, and data for each dose 
represent a minimum of three replicates. Injections were made into 1-8 cell stage embryos 
using a pressure injector (Nanoject II, Drummond Scientific Company. Broomall, PA). 
Pre-pulled needles (mjcro-tips, World Precision Instruments Ltd. Aston, Stevenage) were 
used to deliver 2.3 or 4.6 nl of morpholino. MOs of the following sequences were 
injected: dnmt3 MO (5' CACATTTTCCTTTICAACTATGAAT, Splice blocker); dnmt5 
MO (5' TGAACGTCTTCTAGCTGAAATAATA, Splice blocker); dnmt6 MO (5 ' 
TGGTCCTCCA TTGAGTTCATCACAG, Start site translation blocker); dnmt6 mismatch 
MO containing five mismatches to dnmt6 MO (5'-
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TGcTCCTgCATTcAGTTgATCAgAG), dnmt6 MO (5' 
ACACCAGTTTCGCCTTCTTCTCTGC, Start site translation blocker), 3rd dnmt6 MO 
(5' CTCTGCCTGCAACGTAGGGAACAGC, Splice blocker); dnmt7 MO , (5 ' 
GTTCCAGACTAACATTTGTAGCCA T, Start site translation blocker), dnmt7 mismatch 
MO (5'-GTTgCAGAgTAAgATTTcTAGCgAT); dnmt8 MO (5' 
GTGTGT AAAAAGACACTTTCAAAAC, Start site translation blocker). Images were 
captured by using a Cannon Rebel XT digital camera mounted on a Motic SMZ168 
dissecting microscope. 
For mRNA injections, zebrafish dnmt6 (Genbank accession number AB 196917) 
was amplified by RT-PCR using RNA reverse transcribed with M-MLV Reverse 
Transcriptase (Invitrogen Inc. Carlsbad, CA) according to the maufacturer's instructions 
and with 1 ug RNA and an Anc-T primer. PCR was carried out with modified primers to 
include 5 base pair changes to the translation start site region at the 5 'end of the gene, but 
maintaining a KOZAK sequence (Forward pnmer 5' 
TCT ACCA TGGACACAATGGAAGACCA), and to incorporate a His-tag signal prior to 
a stop codon m the 3'end (Reverse pmner 5' 
TTAGTGGTGATGGTGATGATGAGTCCGACGCAGGCGAA). The amplified 
product was cloned into pCR 2.1 vectors (TOPO TA cloning kit, Invitrogen Inc. 
Carlsbad, CA) and mRNA was synthesized (mMessage mMachine kit and Poly (A) 
Tailing kit, Applied Biosystems/Arnbion. Foster City, CA) with the manufacturer's 
instructions. 
For RT-PCR, embryos were collected at 10-12 hours, and in some instances 24 
hours post fertilization. Collected embryos were either experimental (injected with splice 
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blocking MOs) or control (injected with Danieau). Total RNA was isolated using TRizol 
reagent (Invitrogen Inc. Carlsbad, CA) with the manufacturer's instructions and cleaned 
using the RNeasy clean-up kit (Qiagen Inc. Valencia, CA) with the manufacturer's 
instructions. RT was carried out as described above and PCR was performed with 
primers spanning the exon to be excised (Figure 4.5). For dnmt3 (AB196914) primers 
flank exon 5 with Forward Primer 1 (dnmt3F1 5'- GGTGGCCTTCATTAAACCTG) and 
Reverse Primer 1 (dnmt3Rl 5'- ACATCGGATATGCTGCTTCC) producing an 
amplicon of 1710 bp, and the expected size of the amplicon upon excision of exon 5 is 
211 bp. A second reverse primer, dnmt3R2 (5'- CTACGGATCTTAACGGTCTG), was 
designed to produce an amplicon of 2573 bp in the presence of exon 5, and 1074 bp in its 
absence (Figure 4.5). For dnmt5 (AB196916) primers flanked exon 5 with Forward 
Primer 1 (dnmt5Fl 5'- CCTGCTCAGAAACTCTGCTG) and Reverse Primer 1 
(dnmt5R1 5'- TGGCTCAACGTCTTCCTCTT) producing an amplicon of 1717 bp, and 
the expected size of the amplicon upon excision of exon 5 is 248 bp. A second reverse 
primer, dnmt5R2 (5 '- TCCCA TTCACTGA TCGTGGTGT), was designed to produce an 
amplicon 2377 bp, and 908 bp with the removal of the target exon (Figure 4.5). For 
dnmt6 (AB 196917) the ex on to be removed contained the A TG translation start site. 
Primers spanning this exon were dnmt6F (Forward 5'- GCCAACATTCTGCAAGTCCT) 
and dnmt6R (Reverse 5'- GCCAAACCATGTAACCCATC), producing a transcript 707 
bp, and an expected size of 356 bp upon excision of the exon. 
For western blotting, embryos were collected at 12 and 24 hours post fertilization, 
and homogenized in SDS sample buffer (Westerfield 2000). Samples were boiled for 4 
minutes and supernatants were collected following 5 minutes centrifugation. Protein was 
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separated by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), and transferred to polyvinylidene difloride membrane. Presence of His-tag 
protein was determined by hybridization with primary antibody mouse anti-His (Zymed 
Laboratories, Invitrogen Inc. Carlsbad, CA), and secondary antibody horseradish 
peroxidase (HRP)-goat anti-mouse IgG (Zymed Laboratories, Invitrogen Inc. Carlsbad, 
CA), followed by 3,3'-Diaminobenzidine (DAB) visualization (Roche Ltd. Mississauga, 
ON) with the manufacturer's instructions. 
4.3 Results and Discussion 
Dnmt3, dnmt5, and dnmt7 knockdown 
To determine dnmt3 and dnmt5 methyltransferase function in zebrafish 
development, we injected splice-blocking antisense MOs into 1-8 cell stage zebrafish 
embryos. These two genes are most similar to mammalian Dnmt3b, and likely represent a 
tandem gene duplication (Smith et al. 2005). Given dnmt3 and dnmt5 are 72% similar at 
the amino acid level, the possibility of fu nctional redundancy is quite high, and therefore 
co-injections were carried out. However, dnmt7 as well as dnmt4 which shows highest 
homology of the zebrafish dnmts to mammalian Dnmt3b are also present, and co-
injections of more than two gene MOs were also undertaken. 
Both the dnmt3 and dnmt5 MOs were designed to excise an exon in the 5' region of 
the respective genes. In both instances, the exons to be excluded were not divisible by 
three, and therefore resulted in nucleotide frameshifts when not included in the 
transcripts, likely producing nonsense products (Figure 4.5). 
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Embryos injected with 1 ng, 5 ng, and 10 ng of either dnmt3 or dnmt5 MO 
independently did not demonstrate any observable penetrant phenotype. As well, 
embryos receiving co-injections of 3 ng of each dnmt3 MO and dnmt5 MO, and embryos 
receiving 6 ng of each MO, did not demonstrate any abnormalities in development. In 
order to determine whether these results indicated a lack of observable relevance for 
dnmt3 and dnmt5 in development, or whether the MOs were ineffective, embryos injected 
with I 0 ng of each MO in single MO injections, and a co-injection of both MOs (6 ng 
each) were collected at 12 hpf. Presence of disrupted splicing was determined by RT-
PCR (Figure 4.6). Although the splice blocking MOs would not alter maternally supplied 
transcripts, we would expect to be able to observe altered splicing of zygotic transcripts 
by RT-PCR. Unfortunately, dnmt3 MO did not result in removal of the large exon, and 
dnmt5 MO appears at this stage to be only moderately effective in targeting the transcript 
of interest and resulting in the large exon excision. Given that, for splice blocking 
injections, a greater amount of MO must be injected in order to target transcripts during 
the narrow window before they are properly edited following transcription, single 
injections of dnmt3 MO and dnmt5 MO were carried out with 15 ng and 30 ng of the 
respective MOs. Embryos collected at 6 hours, followed by RT-PCR with extracted 
RNA, indicate that even at these very high dose injections there was no evidence of exon 
excision upon dnmt3 MO injection, and only mild efficacy of exon excision occurring 
with dnmt5 MO injections (Figure 4.7). 
Treble injections were carried out with dnmt3, dnmt5, and dnmt7 MOs alongside 
above mentioned injections prior to determining lack or moderate efficacy of dnmt3 and 
dnmt5 morpholinos. As would be expected given the RT-PCR results from dnmt3 and 
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dnmt5 injections, no phenotype wa ob erved in the developing embryo . However, this 
treble injection is a good example of the types of injections that may be performed in 
order to begin tea ing apart function of the various zebrafish dnmts. Once working MOs 
for dnmt3 and dnmt5 are obtained, functional overlap from all three gene may be 
determined by injecting lower doses of each of the MOs. AI o, for instance, a co-
injection of dnmt3 and dnmt7 MOs may provide insight into the function of the CH-
domain found in these two gene , and highlight specific roles of dnmt3 beyond any 
overlapping function with dnmt5. This is not a domain typically found in DNA 
methyltransferases, nor in any of the other zebrafish dnmt gene , and its function here i 
not known. Although there was no phenotype in dnmt7 knockdown embryos, thi MO 
was demonstrated to alter methylation at at least one gene (Shimoda et al. 2005), and 
perhaps when co-injected with dnmt3 MO, observable developmental defects may result. 
dnmt6 and dnmt8 gene knockdown 
Another very logical co-injection based on similarity to each other and potential 
overlap in function is to knockdown dnmt6 and dnmt8, which show the greatest similarity 
to mammalian Dnmt3a (amino acid identity 81 % and 76o/£ re pectively), and which are 
70% similar to each other at the amino acid level. Studies in mice have uggested that 
Dnmt3a may be most relevant for gene specific methylation, and thereby lineage 
determination. The importance of Dnmt3a is underlined by the lethality that occur 
shortly after birth in mice lacking Dnmt3a. Additionally, of the six de novo 
methyltransfera es in zebrafish, dnmt6 and dnmt8 are the only two that show high 
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similarity to Dnmt3a, as the others are more similar to Dnmt3b, simplifying the number of 
genes requiring targeting. 
Prior to performing co-injection experiments, a morphant phenotype was observed 
based on dnmt6 MO injections alone. Injections of a relatively low dose of dnmt6 MO (3 
ng or less) produced results that were in agreement with the findings of Shimoda et al. 
(2005) which indicated a lack of phenotype (Table 1). However, we observed several 
developmental abnormalities when MO doses were increased to 5-l 0 ng injections 
(Figure 4.8). 
Firstly, a dose response was carried out to determjne a range of phenotypes (Table 
4.1 ). Although all ranges of phenotype were detected at each of the doses, a higher 
frequency of less severe or more severe phenotypes corresponded with lower dose and 
higher dose injections, respectively. Penetrance of phenotype increased with increasing 
dose (Table I). 
Less severe morphants demonstrate one kink, or several subtle kinks, in the anterior 
posterior axis (Figure 4.8). With this less severe phenotype, fry 72 hpf and older are 
capable of swimming in a more or less straight line. More severe morphants demonstrate 
a lateral curvature, so that the embryos take a U-shape, and fry are incapable of 
swimrrung in a straight line, moving only in circles when attempting to swim. As well, 
undulations in the notochord were particularly pronounced (Figure 4.9 and Figure 4.10). 
At very rugh doses of dnmt6 MO (10 ng) an increased incidence of embryos 
demonstrating non-specific necrosis occur, also resulting in a higher death rate, but as 
Figure 4.11 i11ustrates this is not true in all cases. In many instances, these more severe 
morphants with very severely disrupted notochords do not demonstrate overall necrosis, 
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nor do the notochord abnormalities resemble those typical of non-specific effect. At these 
high doses, there is some reduction in head size, and abnormal eye development; again, 
however, these do not appear entirely similar to what is observed in p53 mediated non-
specific effects. Notochord undulations are also accompanied by pericardia! edema, and 
often absence of either one or both pectoral fins, and reduced tail length (Figure 4.11 and 
Figure 4.12). Whether some of these effects are non-specific may be determined by 
identifying a second functional dnmt6 MO, and lower dose co- injections may provide 
further insight. 
Control injections with dnmt6 mismatch MO (same sequence as dnmt6 MO with 5 
base pair mismatches) did not result in any observable phenotypes, even when carried out 
at similarly high doses (Table 4.1 and Figure 4.13). This demonstrates that this 
phenotype is not due to toxicity from the presence of any MO, the process of injection, or 
the buffers used and supports that it is a direct result of dnmt6 removal. 
In order to demonstrate specificity of the dnmt6 MO, duplication of phenotype has 
been attempted with two additional different MOs designed against dnmt6 transcript, but 
with non-overlapping sequence to the first MO. Phenocopying the morphants has proven 
difficult given one attempted translation blocking morpholino (2nd dnmt6 MO) causes 
embryonic death at low doses, and severe necrosis, typical of off-target effects (Figure 
4.14), while another splice blocking MO (3rd dnmt6) was not effective and did not result 
in splicing verified by RT-PCR (Figure 4.15). 
Regardless of the high toxicity of the 2nd dnmt6 translation blocking MO, co-
injections of dnmt6 MO and 2nd dnmt6 MO were carried out at levels that do not incur 
highly penetrant phenotype with dnmt6 MO (5 ng) and levels that are low toxicity in 2nd 
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dnmt6 MO injections (2 ng) in order to determine if the 2nd dnmt6 MO potentiated the 
disrupted notochord phenotype. In thi s instance, the incidence of kinked or disrupted 
notochord was not increased above levels that would be expected from 5 ng alone of 
dnmt6 MO (Table 4.2). This indicates that either one of the MOs is not targeting dnmt6, 
or even possibly, that neither MOs are on target. Clearly, injections of the 2nd dnmt6 
accompanied with a p53 MO may be carried out in order to determine if there is presence 
of phenotype (i.e. notochord disruption) that is being masked by the high degree of 
necrosis through the trunk region and head that is caused by injections with this MO 
above 2 ng. 
Co-injections were carried out to determine knockdown specificity with dnmt6 MO 
and a His-tagged mRNA that had a modified ATG site so as to not complementary base 
pair with the dnmt6 MO, but still maintain a Kozak sequence. Future rescue attempts 
may also consider designing the mRNA so that the amino acid sequence is maintained, 
and changes to mRNA are based on the degenerate code. 
Although there does appear to be some amelioration of phenotype with the rescue 
injections (29% showing phenotype after rescue vs. 44% without rescue), this difference 
was not statistically significant Ci=L459, df=l, 0.25>p>0.10, a=0.05) and cannot 
satisfactorily determine dnmt6 MO as specific (Table 4.3). Western blots carried out with 
protein extracted from 12 and 24 hpf injected embryos and anti-His antibody 
demonstrated no presence of the His-tag. This indicates that the modified injected mRNA 
did not result in dnmt6 protein levels that may be detected by western blot, and/or 
possibly the transcript is quickly degraded following injection (Figure 4.16). Another 
possibility is that, despite efforts to de-yolk embryos prior to collection for western 
90 
blotting, high levels of yolk protein were still apparent when performing western blots, 
making it difficult to load enough embryo specific protein to facilitate signal detection. 
Additionally, we were unable to demonstrate efficacy of knockdown of native dnmt6 by 
western blotting given the lack of cross-reactivity of tested antibodies to zebrafish dnmt6. 
Although the phenotype that was obtained with these injections is not typical of 
non-specific effects and is not due to general toxicity of the MO or injection technique, 
our inability to identify an effective second MO, effectively rescue the phenotype or 
monitor protein levels in our morphants allows for the possibility that the phenotype 
generated was either partially or solely due to non specific or mis-targeting effects. 
Co-injections were also carried out with dnmt6 MO and an A TG start site blocking 
MO against dnmt8. This experiment, if resulting in a phenotype, would not only provide 
evidence for overlap between dnmt6 and dnmt8, but would also offer some support for 
the dnmt6 MO as specific. However, the designed dnmt8 MO also results in high levels 
of necrosis, reduced embryo size, abnormal trunk and tail development and embryonic 
death at low doses. This MO is also therefore a candidate for carrying out co-injections 
with a p53 MO that may allow for a specific phenotype to be determined without the 
complication of overall necrosis, reduced embryo size, and curled tail. Although 
additional dnmt8 MOs may be designed in the S'UTR, splice blocking MOs targeting 
dnmt8 are not possible at this time given the low sequence quality available for this gene 
at the genomic level. 
The notochord has a dual role as it serves not only as the axial skeleton to the 
developing embryo until other elements develop, such as the vertebrae, but is also a 
source of midline signals that pattern surrounding tissues (Stemple 2005). Notochord 
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tissue is most closely related to cartilage. As such, in higher vertebrates, this ti sue also 
becomes ossified where vertebrae form, while intervertebral areas contribute to the 
nucleus pulposis of vertebral discs (Stemple 2005). With respect to its function as a 
source of signalling to surrounding tissues during development, the notochord is involved 
in specifying ventra] fates in the central nervous system, controlling some aspects of left-
right asymmetry, inducing pancreatic fates, determining venous versus arterial identity of 
major axial blood vessels, specification of the cardiac field, as well as specifying a variety 
of cell types in forming sornites (Stemple 2005). Several of the additional phenotypes 
observed in dnmt6 MO injections may therefore be in keeping with an improperly 
differentiated notochord, incapable of carrying out normal signalling functions. 
Notochord cells are specified during gastrulation, arising in the shield region. The 
first major transition in notochord development is the formation of molecularly and 
morphologically distinct chordamesoderm (Stemple 2005). Between 6 and 12 hpf, 
through a number of cell movements, the chordamesoderm cells come to lie at the dorsal 
midline of the embryo (Figure 4.17 and Figure 4.18) (Stemple 2005; Solnica-Krezel 
2006). Starting around 20 hpf, the chordamesoderm cells begin to differentiate to mature 
notochord, as cells secrete a thick extracellular sheath, and they also acquire vacuoles 
which provide hydrostatic pressure that, in combination with the sheath, offer the rod-like 
structure of the notochord (Figure 4.19) (Stemple 2005). For proper transition from 
chordamesoderm to mature notochord, down-regulation of genes involved in early 
development is required, as well an increase in mRNA for genes involved in mature 
notochord formation. Without down-regulation of certain regulatory and structural genes, 
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notochord differentiation may become arrested (Hawkins et al. 2008). Notochord cell 
continue vacuolation and differentiation until 36 hpf (Anderson et al. 2007). 
A number of identified mutants have already provided much insight into several 
loci that are required for notochord development (Figure 4.18). Based on phenotypic 
analysis, mutations affecting notochord development may be placed into several 
categories according to the stage of development affected, and further grouped based on 
the specifics of the phenotype (Stemple et al. 1996). Some of these groupings include no 
chordamesoderm formation, fai lure of notochord cells to differentiate and become 
vacuolated, shortened notochord, or the category that seems most similar to dnmt6 
morphants, notochords that are folded or undulate (Stemple et al. 1996). 
As one might imagine, in instances where the notochord fails to be specified, lack 
of signalling results in very severe defects for the embryo, as is seen in mutants of the 
floating head (jlh) locus (Figure 4.20). Clearly, mutations affecting notochord 
development have profound effects on body patterning (Anderson et al. 2007). Although 
several loci have been found to be relevant for signalling, the majority have been 
identified as being important for structural aspects of notochord function (Stemple 2005). 
For example, in the category of mutants where notochord differentiation is disrupted, as 
with mutants bashful, grumpy, sleepy, sneezy, happy, and dopey, phenotypically, embryos 
are often shortened, and at the molecular level, secretion by the cells or notochord sheath 
components are defective (Figure 4.21). 
While the abovementioned mutants have been characterized at the molecular level, 
the group most similar to dnmt6 morphants, demonstrating well-differentiated 
notochords, but that are distorted in dorsomedial and/or mediolateral planes, have not 
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been so characterized (Anderson et al. 2007). This group of mutants includes Levianthan, 
gulliver, crash test dummy, zickzack, quasimodo, kinks, and wavy tail (Figure 4.22) 
(Odenthal et al. 1996; Stemple et al. 1996). It is difficult to categorize this group as to 
when they may be having an effect during notochord development, as the phenotypes 
could be arising for a number of potential reasons (Odenthal et al. 1996). For instance, 
these loci may control early events such as general aspects of cell movement during 
gastrulation and proper convergence and extension of the chordamesoderm. With 
morphogenesis of the tail affected, notochord undulations may result from a lack of 
space, if the tail is shortened (Stemple et al. 1 996). Alternatively, the e loci may be very 
relevant for the transition from chordamesoderm to mature notochord and interactions 
with the surrounding tissues. Very possibly, this phenotype could also result from 
improper adhesion to the notochord sheath or an increase in cell division in the 
notochord. The undulating notochord of dnmt6 morphants may be further explored once 
evidence for knockdown specificity has been gained. 
4.4 Conclusion 
Due to some evidence of functional overlap between Dnmt3a and Dnmt3b m 
mammals, along with the potential redundancy in the number of dnmt3s present m 
zebrafish, a number of combinations of co-injections will no doubt provide new insights 
into the de novo DNA methyltransferases, their overlap, and their specific functions. 
Imperative to this work will be the development of specific, efficient MOs against each of 
the transcripts. 
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At the outset, we had imagined co-injections with MOs would result in 
developmental abnormalities, and that these embryos may then be collected for 
microarray analysis. Although we present here onl y one instance where phenotype was 
observed following MO injection, we have yet to perform co-injections with effective 
specific MOs. Once a set of MOs is obtained for each of the de novo methyltransferases, 
and these are foll owed with microarray analysis, we will then begin to be able to 
determine genes that are candidates for being directly under the control of methylation, or 
at least downstream of genes regulated by methylation. Based on the different co- or 
triple injections etc., we can begin to tease apart which genes may be under the control of 
several of the dnmt3s, and which genes are under specific regulation by only one of the 
dnmt3s. Of course bi-sulfite sequencing of the promoter regions of the genes of interest 
will provide direct evidence for disrupted methylation following injection, and ultimately 
provide a set of genes that may be used to study many of the remaining unanswered 
questions regarding dnmt3 targeting, and how the epigenetic layers are involved in 
programming embryonic development. 
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Figure 4.1 Schematic of a MO oligonucleotide complimentary base pairing to mRNA. 
MOs are synthesized to target specific transcripts of interest, and the backbone of the MO 
oligonucleotide is unrecognizable to cellular enzymes and is not degraded (with 
permission from Jon D. Moulton, Gene Tools, LLC). 
99 
A) B) 
Figure 4.2 Schematic of mechanisms by which MOs disrupt gene function . A) MOs are targeted to the 5'UTR of the mRNA 
and prevent progression of the initiation complex . B) A pre-mRNA splice-site is targeted resulting in a mispliced protein (with 
permission from Jon Moulton, GeneTools, LLC). 
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Figure 4.3 MOs may block nuclear processing. Exon-intron or intron-exon boundaries 
may be targeted, resulting in an exon excision, or intron inclusion. Here exon 2 is 
excised, and the product may be characterized by RT-PCR (adapted from Gene Tools, 
LLC. www.gene-tools.com). 
101 
A) B) 
Figure 4.4 Morpholinos are microinjected into embryos. A) Injections are performed 
using a microinjector, a micromanipulator, and dissecting microscope. B) Loading the 
needle with phenol red dyed morpholino. C) The needle punctures through the chorion of 
an embryo and MO is delivered into the yolk of the developing embryo. D) When phenol 
red is used, a red spot may be observed when injection is properly perfonned. E) 
Embryos are raised in embryo medium and observed for phenotype. 
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Figure 4.5 Schematic of dnmt3 and dnmt5 5' genomic tructure. The exons to be excised 
in the presence of targeting MOs are indicated, as wel l as the flanking primers used to 
characterize the RT-PCR products. Schematic of amplicon are represented below the 
genomic tructure (Coloured bars repre ent exons, black line between coloured bars 
represent introns). 
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Figure 4.6 MO injected and control embryos were collected at 10-11 hpf, RNA was 
extracted, and RT-PCR was performed. Lane 1: 10 ng dnmt3 MO injected embryos. RT-
PCR with dnmt3FIR2 primers. Expected amplicon 2573 bp, and if exon excised 1074 bp. 
Lane 2: 10 ng dnmt5 MO and RT-PCR with dnmtSFlRl. Expected amplicon 1717 bp, 
and if exon excised 248 bp. Lane 3: Embryos co-injected with dnmt3 and dnmt5 (6 ng 
each). RT-PCR primers dnmt3F1R2. Lane 4: Embryos co-injected with dnmt3 and 
dnmt5 (6 ng each). RT-PCR primers dnmt5 FlRl. Lane 5: 1 kb Plus DNA ladder. 
Lane 6. Danieau control injected embryos. RT-PCR primers dnmt3FlR2. 
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Figure 4.7 MO injected and control embryos were collected at 5-6 hpf, RNA was 
extracted and RT-PCR was performed. Lane 1: 1 Kb Plus DNA Ladder. Lane 2: 15 ng 
dnmt3 MO and RT-PCR with dnmt3F1Rl primers. Expected amplicon 1710, and if exon 
excised 2 11 bp. Lane 3. 15 ng dnmt3 MO with dnmt3F1R2 primers. Expected amp1icon 
2573 bp, and if ex on excised 1074 bp. Lane 4. 30 ng dnmt3 MO with 
dnmt3FlR I primers. Lane 5. 30 ng dnmt3 with dnmt3FlR2 primers. Lane 6: 30 ng 
dnmt5 MO and RT-PCR with dnmt5F1Rl primers. Expected amplicon 1717 bp, and if 
exon excised 248 bp. Lane 7: 30 ng dnmt5 MO with dnmt5FlR2 primers Expected 
amplicon is 2377 bp, and if exon excised 908 bp. Fainter band present indicated some 
MO efficacy for dnmt5. Lane 8: lKb Plus DNA ladder. Lane 9: Uninjected control 
embryos. Primers dnmt3F1Rl. Lane 10: Uninjected control embryos. Primers 
dnmt5F1Rl. 
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A) B) 
8 ng 
C) 
Figure 4.8 Embryo phenotype resulting from increased doses of dnmt6 MO. A) Embryos 
injected with 3 ng or less do not demonstrate any phenotype. B) An embryo 
demonstrating several subtle kinks or undulations of the tail and notochord (notochord not 
visible here). C) At increased doses, a greater number of embryos display this U-shape 
lateral curvature and are incapable of swimming in a straight line. Often embryos will 
also have pericardia! edema and pronounced undulations of the notochord. D) Very high 
doses of dnmt6 MO resulted in a shortening of the body, multiple notochord undulations, 
severe pericardia] edema, no fins, and disrupted eye development. Some of this severe 
phenotype may result from non-specific effects. 
106 
A) Wild Type 
dnmt6 MO 
Figure 4.9 A) Photo of wild-type 24 hour embryo demonstrating notochord structure. 
B) Undulations in the notochord and tail of dnmt6 MO injected embryos (8 ng MO). 
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~--------------------------------------------------------------------------------------------
Figure 4.10 Undulations in the tails of zebrafish fry and the kinks in the notochord are 
very evident at later stages (seen here 6 dpf I 0 ng dnmt6 MO injected embryos). Also 
evident is the lack of pectoral fins on the lower fry. 
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Figure 4.11 Comparison of embryos demonstrating low (A), intermediate (B), and severe cell death (C) phenotype mediated 
through p53 activation at 30 hpf with D-G) embryos receiving 16 ng dnmt6 MO injections. Cell death is ob erved as highly 
dense opaque areas. Here, embryos F) and G) more closely resemble phenotypes seen in B) and C) with necrosis evident in tail 
and head regions. Structures in D) in E) on the other hand are more easily distinguished and appear to be simply more severe 
than phenotypes observed at lower dnmt6 MO injection (A, B, and C adapted from Urtishak et al. 2003). 
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Figure 4.12 dnmt6 MO injected 72 hour embryos demonstrating lack of fins (above) or lack of one pectoral fin (below). Also 
apparent is the characteristic disrupted notochord structure (both) and some pericardia! edema (above). 
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Figure 4.13 Control injections with 10 ng dnmt6 mismatch MO. 72 hour hpf embryo seen here, no observable phenotype. 
Ill 
1ng 48 hrs 2ng 48 hrs 
Figure 4.14 Severe cell death phenotype following 2"d dnmt6 MO injection. In a couple of instances, phenotype duplication was 
observed (A), however, most typical results for injections with this MO are seen in B) and C). 
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Figure 4.15 dnmt6 splice block MO (3rd dnmt6 MO) was injected into embryos, and 
embryos collected at 72 hpf, RNA extracted, and RT-PCR performed. Expected nascent 
amplicon is 707 bp, and in the presence of MO, expected amplicon is 356 bp. Similar 
RT-PCR results were obtained for embryos collected at 12 hpf and 24 hpf. Lane 1: 10 ng 
dnmt6 splice MO injected. Lane 2: 20 ng dnmt6 splice MO injected. Lane 3: Danieau 
injected control embryos. Lower bands present in lanes 1 & 2 is also present, though 
fainter, in control sample. Lane 4: RT-PCR positive control (max) . Lane 5: 1 kb Plus 
DNA ladder. 
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Figure 4.16 A) Western blot with protein extracted from embryos injected with His-tagged dnmt6 mRNA. Lane 1: Protein 
marker. Lanes 2-4: Embryos collected at 12 hpf. Lanes S-8: Embryos collected at 24 hpf. Lane 2: Embryos received 0.76 ng 
dnmt6 His-tag mRNA. Lane 3: Embryos received 1.5 ng dnmt6 His-tag mRNA. Lane 4: danieau injected control embryos. 
Lane S-8: Embyos injected with dnmt6 His-tag mRNA that was not modified to be refractive to the dnmt6 MO. This would 
indicate whether the modification at ATG start region was problematic in initial rescue experiments with modified A TG region. 
Lane 9: Positive control His-tag fragment. B) Coomassie Blue stained SDS gel prepared and loaded the same as the gel 
employed for western blot. 
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Figure 4.17 Gastrulation movements in zebrafish. A) Image of live embryo at shield 
stage and (B) the four gastrulation movements, epiboly, emboly (i nternal ization), 
convergence and extension, that occur to transition the blastoderm into (C) an embryo 
with head, trunk and tail rudiments. The embryo elongates from head to tail , and narrows 
along the dorsoventral axis. Abbreviations: Sh, shield ; AP, animal pole; D, dorsal; V, 
ventral; VP, vegetal pole (adapted from Solnica-Krezel 2006). 
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Figure 4.18 Notochord development and mutations that act at particular notochord 
developmental stages. A) The chordamesoderm progenitor region of the shield is 
indicated between arrow heads. B) The chordamesoderm and C) the differentiated 
notochord (with permission from Stemple 2005). 
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Figure 4.19 Structure of zebrafish notochord. A) Lateral view of a 24 hpf zebrafish tail 
showing the main features of the notochord. The floor plate is located dorsally to the 
notochord, in the ventral part of the forming spinal cord. The hypochord is located 
ventrally to the notochord. B) Schematic of lateral and cross-sections of the notochord. 
The floor plate and hypochord act as cables running along the top and bottom of the 
notochord. C) The notochord, the floor plate, and the hypochord express type II collagen 
(Yan et al., 1995 from Stemple 2005). cc, central canal; fp, floor plate; hy, hypochord; no, 
notochord; nt, neural tube (with permission from Stemple 2005). 
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A) Wild Type 
Figure 4.20 Live images of 24 hpf zebrafish embryos. A) wild-type embryo (arrow 
indicates notochord). B) flh mutant where chordamesoderm specification is disrupted 
(arrowhead indicates lack of notochord) (adapted from Odenthal et al. 1996). 
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Figure 4.21 Differential interference contrast (DIC) micrographs of 24 hpf zebrafish 
embryos. A) wild-type embryo; B) sleepy mutants; C) dopey mutants; and D) sneezy 
mutants demonstrate notochord cells that fail to vacuolate. These loci encode 
components of the notochord membrane or components of the secretory pathway (with 
permission from Stemple et al. 1996). 
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Figure 4.22 Images of zebrafish mutants gullivar (gul), leviathan (lev), trilobite (tri), and 
knypek (kny). A wavy notochord is apparent in A) gul and B) lev embryos by 28 hpf. C) 
By 72 hpf gul mutants notochord has straightened, though a severe head malformation is 
still apparent (bottom). F and F') By 96 hpf lev mutants, in contrast to gul, have an 
exacerbated notochord phenotype that shows both lateral (F) and dorsal-ventral (F') 
flexures. Gastrulation mutations also show folded notochord phenotype in D) tri and E) 
kny mutants at 72 hpf (with permission from Stemple 1996). 
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Table 4.1 Dose Response for dnmt6 MO Injections and Control Injections. 
Morpholino Data Total Death Embryos with 
and Amount Rate Phenotype (%) 
injected (%) 
dnmt6 Sum of embryos with phenotype 0 47 0 
mismatch Sum of embryos injected 181 
5 ng Sum of embryos survived 96 
dnmt6 Sum of embryos with phenotype 0 59 0 
mismatch Sum of embryos injected 98 
10 ng Sum of embryos survived 40 
0 ng Sum of embryos with phenotype 0 25 0 
(Injection Sum of embryos injected 428 
buffer+ Sum of embryos survived 321 
injection dye) 
dnmt6 MO Sum of embryos with phenotype 0 15 0 
3 ng Sum of embryos injected 95 
Sum of embryos survived 81 
dnmt6 MO Sum of embryos with phenotype 14 22 19 
5 ng Sum of embryos injected 94 
Sum of embryos survived 73 
dnmt6 MO Sum of embryos with phenotype 20 15 33 
6 ng Sum of embryos injected 71 
Sum of embryos survived 60 
dnmt6 MO Sum of embryos with phenotype 77 10 35 
7 ng Sum of embryos injected 245 
Sum of embryos survived 220 
dnmt6 MO Sum of embryos with phenotype 119 30 47 
8 ng Sum of embryos injected 360 
Sum of embryos survived 252 
dnmt6 MO Sum of embryos with phenotype 43 37 45 
10 ng Sum of embryos injected 152 
Sum of embryos survived 96 
0 ng Sum of embryos with phenotype 0 6 0 
Non-injected Sum of embryos injected 266 
control Sum of embryos survived 249 
embryos 
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Table 4.2 dnmt6 MO and 2nd dnmt6 MO co-injections. 
Mo 
Injected Ofo 0/o 
and n Phenotype Death 
Amount injected (of survived) rate 
5ng 
dnmt6MO 12 11 
+ 0.5 ng 18 (2/16) (2/18) 2nd dnmt6 
MO 
5ng 
dnmt6MO 15 27 
+ 1.0 ng 18 (2/13) (5/18) 2nd dnmt6 
MO 
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Table 4.3 dnmt6 MO and rescue mRNA injections. 
MOand % 
% % rescue Phenotype % 
Mo n Phenotype Death mRNA n with rescue Death 
Amount Injected (of survived) rate amount Injected (of survived) rate 
44 10ng MO + 29 
10 ng 84 (16/36) 57 0.5 ng 94 (16/55) 41 mRNA 
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Chapter 5: Identification of Genes Affected by DNA 
Methylation Inhibition in Zebrafish Embryos: 
5-aza-2' -deoxycytidine Treatment and 
Microarray Analysis 
124 
5.1 Introduction 
The Azanucleoside drug S-aza-2' -deoxycytidine (decitabine, SazadC) functions as a 
DNA methylation inhibitor. This cytidine analogue contains a nitrogen atom in place of 
carbon-S of the cytosine ring (Cisernos and Branch 2003). Following metabolic 
conversion into S-aza-2' -deoxycytidine-S' -triphosphate, SazadC may be incorporated into 
DNA by the replication machinery as a substitute to cytidine (Stresemann and Lyko 
2008). Although DNA methyltransferases also recognize SazadC as a natural substrate, 
once the methylation reaction is initiated, and the enzyme forms a covalent bond with 
carbon-6 of the cytosine ring, the reaction becomes blocked with the pre ence of the 
nitrogen atom in place of the carbon-S atom. The enzyme remains covalently bound to 
the DNA, though incapable of carrying out methylation . As the functionality of DNA 
becomes compromised with the trapped methyltransferase, DNA damage signalling i 
initiated and the DNA methyltransferase is degraded (Stresemann and Lyko 2008). 
Therefore, methylation marks are lost not only due to inability of the methyltransferase to 
methylate SazadC, but also through the degradation of the methyltransferases themselves. 
Decitabine is currently used for its antileukemic activity in the treatment of 
myelodyspla tic syndrome (MDS). Although the mechanism(s) responsible for remission 
in patients receiving decitabine remain controversial, one well-supported theory is that the 
promoter regions of tumour suppressor genes are hypermethylated in cancer tissue, and 
with decitabine treatment, hypomethylation results, leading to re-expression of genes 
relevant to differentiation, apoptosis, or senescence of the malignant clone (Griffiths and 
Gore 2008). 
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In addition, 5azadC has been employed both in vitro (Kharroubi et al. 2001; Enright 
et al. 2003; Hattori et al. 2004) and in vivo (Martinet al. 1999; Sasaki and Satoh 2007) to 
investigate normal DNA methylation function, particularly during development. A 
number of genes have been identified that are activated in the presence of 5azadC 
(Kharroubi et al. 2001; Hattori et al. 2004). Developmental abnormalities following 
treatment of embryos with 5azadC include delayed ga trulation and developmental arrest 
at neurula stages in Ciona intestinalis (Sasaki and Satoh 2007), and in zebrafish, 
disrupted gastrulation and aberrant patterning of dorsal mesoderm have been indicated 
(Martin et al. 1999). In mammals, DNA methylation has been demonstrated to be 
essential for development (Li et al. 1992), and when pregnant mice and rats are 
administered 5azadC, defects in pups include long bone defects, supernumerary ribs, cleft 
palate, and vertebral defects (Branch et al. 1999). Clearly, DNA methylation has a very 
critical role in early development, though there is very little knowledge as to the genes 
being affected to produce the above mentioned phenotypes. We present here an in vivo 
approach for 5azadC treatment, followed by microarray analysis, and importantly, in a 
vertebrate model of development, zebrafish, which demonstrate a similar global 
methylation pattern to mammals. Although some genes have been previously identified 
as being affected by methylation in zebrafish development through a candidate gene 
approach following 5azadC treatment (Martin et al. 1999), we hope to provide a more 
thorough examination of affected genes with more recently available zebrafish microarray 
technology. 
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5.2 Methods 
Wild type zebrafish were raised at 28°C usmg standard methods (Westerfield 
2000). Following fertilization, approx imately 50 experimental embryos were rai ed in 
embryo medium treated with 5-aza-2-deoxycytidine (75 uM) (Sigma, St. Louis, MO) 
while approximately 50 control experiment embryos were raised in embryo medium. 
Optimal concentrations of 5-aza-2-deoxycytidine were previously determined (Martin et 
al. 1999), and confirmed here. Embryos were treated with 5azadC for 24 hours, 
following which embryos were collected as outlined below. 
Approximately 40 embryos were collected per sample at 24 hours. Although 
staging is rendered difficult by delayed development and very often disrupted tail 
morphology upon 5azadC treatment, embryos with a heartbeat were determined to be 24 
hpf. Total RNA was extracted from whole embryos using TRizol reagent (Invitrogen Inc. 
Carlsbad, CA) with the manufacturer' s instructions, genomic DNA contamjnation wa 
removed with DNAse I treatment (Roche Ltd. Mississauga, ON), and thi s wa followed 
with a final purification using the RNeasy clean-up kit (Qiagen Inc. Valencia, CA) with 
the manufacturer's instructions. 
Aliquots of RNA were prepared for University Health Network (UHN) microarray 
center (Toronto, ON) and for quantitative real-time rever e tran cription polymerase 
chain reaction (qRT-PCR) reaction . 5azadC RNA was Cy5-labelled and control RNA 
was Cy3-labelled (Quick Amp Labeling kit, Agilent Technologie . Mississauga, ON) 
with the manufacturer's instruction and gene expression changes in 5azadC treated 
embryo versus control embryos were determined by hybridi zation of labeled cRNA to 
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Agilent 44 K zebrafish oligonucleotide microarrays (Hi-RPM Gene Expression 
Hybridization Kit, Agilent Technologies. Mississauga, ON). Three 44K zebrafish 
microarrays were hybridized with three independent 5azadC treated embryo samples and 
control embryos. Dye-swap experiments were not performed. The arrays were 
hybridized at 20 rpm for 17 h at 60 oc in a hybridization oven. Microarray analyses were 
performed at UHN microarray center. Arrays were scanned in the Agilent G2565BA 
DNA Scanner and quantified using Agilent Feature Extraction (version 9.5) and the atny 
data was analyzed using GeneSpring (version 7.3.1. Agilent Technologies. Mississauga, 
ON). Features with intensities at or below average background levels were filtered out of 
the data set. Significant differences between 5azadC treated embryos and control 
untreated embryos were determined by signal fold differences of ~2. These data have 
been deposited m NCB Is Gene expression Omnibus (GEO, 
http://www.ncbi.nlm.nih.gov/geo/). 
For gene validation following rrucroarray analysis qRT-PCR was performed 
according to the manufacturer's protocol (LightCycler-2.0 Carousel Based System and 
LightCycler DNA Master SYBR Green I, Roche Ltd. Mississauga, ON). For RT 
reactions 1 ug RNA was reverse transcribed with M-MLV Reverse Transcriptase using 
Anc-T primer (Invitrogen Inc. Carlsbad, CA). qPCR reactions were performed using 2 ng 
eDNA and primers specific for the various genes (Table 5.1 ). Relative expression of 
genes in 5azadC treated embryos compared to untreated control embryos was determined 
by LightCycler Data Analysis (LightCycler Software 4.0) and Relative Expression 
Software Tool (REST) (Pfaffl et al. 2002). Gene expression of target genes was 
normalized to a non-regulated reference gene, elongation factor elf4ela using REST 
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(Pfaffl et al. 2002). RNA used in reverse transcription for qRT-PCR was the same as that 
used for microarray experiments, and here, the three independently treated samples and 
their controls were examined in triplicate for each gene validation. Prior to determining 
relative expression, standard curves were determined and amplification efficiencies for 
the different primer sets were established. These values were used in calculating relative 
quantity PCR values. No template controls were also carried out alongside qRT-PCR 
reactions and dissociation curve analyses were performed. 
Embryo fixation and DIG-labeled in situ hybridization were performed as described 
by Westerfield (2000). The RNA probe for the zebrafish foxn4 corresponds to the 
following nucleotides: foxn4 probe 998 nt (AF198446 nucleotides 443-1440. Forward 
pnmer 5 '- CGGCCAGATTTCACTAGCTC, Reverse pnmer 5' -
ACGTCAGTGTGGACCGTGTA). 
5.3 Results and Discussion 
To determine methyltransferase function m zebrafish development, we treated 
zebrafish embryos with 5azadC and found that the embryos displayed several 
developmental abnormalities. The most apparent disruption occurred to the notochord of 
the developing embryos. The tail and trunk length was often reduced, and in several 
instances, embryos lacked, in part or in whole, their notochord (Figures 5.1, 5.2 and 5.3) 
(also in Martin et al. 1999). In embryos where the notochord appeared to be mostly 
present, the notochord demonstrated a wavy or folded morphology. As well , somites and 
muscle underwent abnormal development (Martin et al. 1999). Another evident 
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phenotype that became more pronounced by 48 hpf was severe pericardia! edema 
(Figures 5.2 and 5.3). Head size was often reduced, and very often eye development was 
affected. Embryos treated with 100 uM 5azadC demonstrated a higher death rate than 
lower doses, and therefore 75 uM treatments (death rate 15%) were used for treatments 
preceding microarray experiments. However embryos treated with the higher dose that 
did survive to 48 hours demonstrated a more severe phenotype (Figure 5.3). For a more 
complete analysis of phenotype resulting from 5azadC treatment of zebrafish embryos 
refer also to Martin et al. ( 1999). 
Eighty-five genes were identified as being either induced or repressed by two-fold 
or more in embryos upon exposure to 75 uM 5azadC in all three repeated microarray 
experiments. If less stringent criteria are employed, such as 1.5-fold or greater change in 
at least two of the microarray experiments, 2347 genes with altered expression can be 
identified. A number of the genes with altered expression are known to be involved in 
differentiation, proliferation, CNS and skeletal muscle development. We verified a 
number of genes by qRT-PCR and found five of twelve genes examined are significantly 
induced or repressed in 5azadC exposed embryos relative to non-exposed control 
embryos by 1.5 fold or more (Table 5.1). The high false positive rate (58%) may be due 
to the fact that dye-swaps were not incorportated into the experimental design, and that 
only three replicates were performed. 
Of the genes with significantly altered expression, transcription factor fos 
demonstrated the greatest increase in expression in response to 5azadC treatment 
compared to control embryos, with an average 8-fold increase. Fos is a component of the 
activator protein-1 (AP-1) transcription factor complex. When dimerized with members 
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of the Jun family to form the AP-1 complex, Fos is involved in gene regulation in 
processes of proliferation, differentiation, and transformation (Hess et al. 2004). Future 
investigations through bisulfite sequencing might reveal changes in DNA methylation 
that may be occurring during development in the promoter region of fos, or whether up-
regulation seen here is due to mis-regulation of upstream genes. 
In order to examine the biological significance of down-regulation of the winged 
helix/forkhead transcription factor, foxn4, we performed in situ hybridization on 5azadC 
treated embryos and control embryos. The Fox family of transcription factors in known 
to be involved in several aspects of development including cell specification, 
differentiation and proliferation (Cohen and Morrisey 2008). Specifically,foxn4 has been 
demonstrated to have a role in formation of the atrioventricular canal, cardiac looping, 
and atrioventricular conduction (Chi et al. 2008; Cohen and Morrisey 2008) as well as 
retina and central nervous system development (Danilova et al. 2004). Expression of 
foxn4 in normal zebrafish embryos has been previously characterized (Danilova et al. 
2004) and demonstrates ubiquitous expression through to gastrula stages at which point 
tissue specificities begin to be observed. By 14 hpf, foxn4 is expressed in three cell 
clusters in the forebrain region which will fuse and migrate anteriorly to form circular 
structures corresponding to the olfactory placode by 24 hpf. Expression is also apparent 
starting at 14 hpf in the anterior midbrain, and becomes restricted by 24 hpf to the 
peri ventricular layer of the tectum (Danilova et al. 2004) and around 20 hpf expression in 
the retina begins in the ventronasal region (Danilova et al. 2004 ). In situ analysis 
comparing normal zebrafish embryos (Figure 5.4) to 5azadC treated embryos 
demonstrated primarily a loss of expression in the olfactory placode and likely in the 
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retina (Figures 5.5 and 5.6). Some embryos also demonstrate loss of expression in the 
tectum, though this does not seem to be consistent across all treated embryos (Figure 5.6). 
This indicates that although qRT-PCR suggests a 3-fold decrease in expression of foxn4 
in 5azadC treated embryos, this down-regulation may reflect a range of disrupted 
expression in vivo. 
vsx2 is another gene involved in retina development and proliferation. Embryos 
with disrupted vsx2 expression have reduced eye size (Vitorino et al. 2009). In 5azadC 
treated embryos we see a 2.7 fold decrease in expression at 24 hpf. Interestingly, foxn4 
has been shown to be down-regulated by vsx2 in amacrine and horizontal progenitor cells 
of the retina. Vsx2, therefore, has been proposed to act as a gatekeeper functioning to 
repress transcription factors responsible for specifying progenitors of other lineages 
(Vitorino et al. 2009). Although in 5azadC treated embryos vsx2 down-regulation is also 
accompanied by foxn4 down-regulation, it will be interesting to discover the upstream 
genes whose mis-regulation results in down-reuglation of these genes and how they are 
involved in development of the severely disrupted retina phenotype. 
5.4 Conclusion 
Although in the past significant information has been gained through a candidate 
gene approach following 5azadC treatment, the more recent availability of zebrafish 
microarrays allow for the identification of a more comprehensive list of affected genes. 
The false positive rate for this microarray experiment is high, which suggests that it may 
be necessary to repeat this approach in the future with larger samples and greater number 
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of repeats in order to provide more robust information. In future investigations, embryos 
may be collected from various stages to identify not only the genes affected in various 
stages of development but may also identify general pathways that are affected. 
Here we have identified a number of genes that appear to be affected by 5azadC 
treatment and, presumably, by decreases in methylation. Interestingly we have 
discovered a number of transcription factors with disrupted expression following 5azadC 
treatment. These factors have been shown to be relevant for different areas of 
development such as CNS and retinal differentiation and development. Future 
investigations may examine in situ expression to determine tissue specificities of the 
disruption, and more importantly, through bisulfite sequencing begin to examine precisely 
which genes are regulated developmentally by methylation, and provide target genes for 
examining further questions surrounding DNA methylation. 
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Figure 5.1 24 hour 75 uM 5azadC treated embryos. Disrupted tail and notochord 
development is evident. 
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C) 
Figure 5.2 75 uM 5azadC treated embryos A & B) 4 days development C & D ) 5 days 
development. Shortened trunk, disrupted notochord, and pericardia) adema are all evident 
phenotypes. Additionally some abnormal eye development and blood pooling may be 
seen in some of the embryos. E) Control: 5-day embryo. 
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Figure 5.3 100 uM 5azadC treated embryos at 72 hours development. Very little eye 
development is observed in these embryos (arrow) and reduced trunk and tail IS even 
more evident, as is reduced head size and pericardia) adema (arrowhead). 
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A) B) 
Figure 5.4 Wild-type 24 hour embryos. A) Untreated foxn4 antisense embryos 
demonstrating normal expressiOn. Green arrows indicate expression in olfactory 
placodes. Some staining is also evident in retina and tectum. B) Control foxn4 sense 
probe shows no staining. 
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Figure 5.5 Wild-type 24 hour embryo treated with 75 uM 5zadC and in situ hybridization 
with foxn4 antisense probe. Relative to untreated embryos, expression in olfactory 
placodes is not evident and at least reduced in retina and tectum. 
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A) 
B) 
C) 
Figure 5.6 Wild-type 24 hour embryos treated with 75 uM SzadC and in situ 
hybridization with A & B) foxn4 antisense probe and C) foxn4 sense probe. In A) no 
staining of olfactory placode (green arrow) is evident and reduced tectum staining (black 
arrow) is evident compared to B) where some cells continue to express foxn4 in the 
tectum (black arrow) and retina (arrowhead). C)foxn4 sense probe shows no staining. 
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Table 5.1 Genes examined by qRT-PCR for expression changes following 5azadC 
treatment. The factor of up- and down-regulation is indicated. For each sample three 
replicates were performed, and in instances where standard error is indicated, three 
replicates for three biological samples were performed. Genes that validated microarray 
results are highlighted (red = up-regulated, green= downregulated, yellow = non-
regulated housekeeping gene). 
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Chapter 6: General Conclusion 
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6.1 General Conclusion 
As the study of epigenetics delves deeper, it is glaringly apparent that the level of 
complexity afforded by epigenetic mechanisms of gene control and the cross talk between 
these modifications gives rise to a system for which we are only beginning to scratch the 
surface in understanding. Implications in areas yet unknown are likely to continue to be 
uncovered. 
Here we have demonstrated the power of using zebrafish embryos to ask a number 
of the questions surrounding DNA methylation in development. Initial steps involved 
identifying and isolating the de novo methyltransferases in zebrafish, of which there are 
six family members. The increased number relative to mammals is likely due to a 
genome duplication event, though in one instance we suggest simple tandem gene 
duplication as a possible origin of one of the genes rather than genome duplication. 
Expression patterns of these genes in developing zebrafi sh embryos demonstrate 
similarities to patterns observed in mammals, suggesting conserved regulation in 
vertebrates. The presence of mRNA transcripts in early stages indicates maternal supply 
of each of the gene products. Following mid-blastula transition the dnmt3s are regulated 
independently demonstrating expression patterns that may be grouped based on whether 
the genes are more similar to mammalian Dnmt3a or Dnmt3b. Those zebrafish dnmt3 
genes most similar to Dnmt3b are more highly expressed relatively early in development, 
showing a decrease by 24 hours of development, suggestive of relevance through to 
gastrula and segmentation periods. In contrast, dnmt8, and in particular dnmt6, zebrafish 
de novo methyltransferases most similar to Dmt3a, demonstrate increasing expression 
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through to 72 hpf and therefore may be relevant for processes such as neurogenesis and 
termjnal differentiation in addition to potential earlier role(s) in embryonic development. 
Not only is the transcript expression pattern observed for dnmt6 and dnmt8 in 
development of particular interest, but also their prevelance in adult bra in tissue. In 
recent years, research in DNA methylation in the CNS has seen a sudden increase given 
its implications in synaptic plasticity and long-term memory formation (Levenson and 
Sweatt 2005 ; Liu et al. 2007), as well as addiction (Hillemacher et al. 2009) and a 
number of mental health disorders such as Schizophrenia, and Fragile X mental 
retardation (Tsankova et al. 2007). In keeping with the idea that DNA methylation 
provides a mechanism for information storage at the cellular level during development, 
the emerging idea is that DNA methylation has been co-opted in the CNS for memory 
storage. DNA methylation in the CNS is dynamic, which also raises questions regarding 
the mechanism of active de-methylation. The CNS, in particular the brain, may provide a 
rewarding tissue therefore for investigating this highly sought yet undetermined 
mechanism. 
In order to achieve our goal of determining the relevance of de novo DNA 
methyltransferases for different stages of normal development we injected MOs against 
dnmt3, dnmt5, dnmt6, dnmt7, and dnmt8. Interestingly, following MO injections 
targeting dnmt6, phenotypes that resulted from notochord malformation were observed. 
The phenotype is consistent with tirrung of expression of this gene; notochord 
specification and formation is coincident with the increase in dnmt6 that commences at 
approximately six hours post-fertil ization. 
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We did attempt some co-injections of MOs agains more than one dnmt3 but, given 
that there are six de novo DNA methyltransferases, and a maintenance methyltransferase, 
knocking down greater numbers of dnmts simultaneously by MO injection becomes 
problematic due to sheer number. Therefore, treatment of zebrafish embryos with 5-
azadC provided a way of interfering with all methylation and, consequently, giving a 
more comprehensive understanding of the overall importance of DNA methylation to 
zebrafish development. This technique accompanied with microarray anal ysis provided 
insight into genes that are either directly or indirectly regulated by methylation. 
One very obvious similarity between the dnmt6 MO knockdown and the 5azadC 
treatment was the effect of both on notochord development and differentiation suggesting 
that DNA methylation is very relevant to those processes. As the notochord phenotype 
was more severe in embryos following 5azadC treatment than in dnmt6 MO knockdown 
embryos, it is likely that other DNA methyltransferases are also involved in notochord 
formation and/or differentiation. Very possibly, based on timing of notochord 
specification, and deterrruned expression, some of the earlier expressed dnmt3s may be 
involved in specification and early formation while dnmt6 (and possibly dnmt8) are 
involved in differentiation. This would be consistent with areas of absence of notochord 
in 5azadC treated embryos, versus an undulating notochord in dnmt6 knockdown 
embryos. Sirrular findings of a transition from Dnmt3b to Dnmt3a have been indicated by 
expression analyses in the development of the CNS in mice (Feng et al. 2005). 
Specifically, we determined through microarray analysis a number of genes affected 
by 5azadC that are involved in differentiation including foxn4, fos, and vsx2. Some of 
these genes may also therefore be relevant to the phenotypes observed in dnmt6 MO 
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knockdown experiments as they have been implicated in heart and eye development. 
Although we did not determine a number of genes as expected to be directly involved 
with notochord differentiation, it is possible that examination of an earlier developmental 
stage may provide further insight. 
Overall, we have demonstrated through the identification of genes homologous to 
mammalian de novo methyltransferase genes, and by identifying similarities observed in 
their transcript expression, that zebrafish embryos are a very favourable system to pursue 
analyses of DNA methylation. We have undertaken investigations into the function of 
DNA methylatransferases in zebrafish development and demonstrated that methylation is 
critical to notochord development, and is also likely relevant to proper somjte, retina, and 
heart development as evidenced by phenotypes observed following morpholino injection 
and/or chemical treatment of embryos with dnmt activity blocbng 5-aza-2'-
deoxycytidine. Furthermore we have begun to identify genes relevant to the 
abovementioned phenotypes that are directly or indirectly regulated by methylation. This 
has been achieved through microarray analysis of 5azadC treated embryos. 
Given these advances, along with the strengths afforded by zebrafish for this area of 
research such as rapid ontogeny and observable live embryos throughout development, 
the presence of epigenetic factors, lack of imprinting, and global methylation patterns, 
this model organism is highly suited to further investigations of DNA methylation and 
epigenetics. Results attained here suggest future investigations with zebrafish embryos to 
be of great impact in our understanding of epigenetic mechanisms of gene control. 
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6.2 Future Directions 
Future investigations should continue to determine presence of other splice 
variants for the zebrafish dnmt3 genes, for which there is some preliminary evidence from 
RT-PCR reactions. In addition, probes of greater nucleotide number may be employed to 
increase specificity in in situ transcript expression analysis, and more comprehensive in 
situ analysis of embryos and adult tissues such as brain will provide further detailed 
information on the regulation and relevance of the different dnmt3 genes to zebrafish 
development. 
The main focus, however, should be to co-inject problematic MOs, discussed in 
chapter 4, with a p53 MO, in tandem with continued development of morpholinos that 
efficiently and specifically knockdown the various zebrafish de novo methyltransferases. 
Most importantly, these MOs should be used in combination with one-another in order to 
determine functional overlap among this family of genes and very likely, when 
homologous dnmts are knocked down simultaneously, developmental phenotypes will be 
observed and may be studied. One might expect these phenotypes to build up to the very 
severe phenotype observed when overall methylation is disrupted by 5azadC treatment. 
Preliminary investigations may be carried out by examining genes indicated by 
5azadC treatments in MO injected embryos by both real-time PCR and/or in situ 
hybridization to determine which of the methyltransferases is relevant to the expression of 
the identified genes. However, rnicroarray analysis following the various MO injections 
will provide specific and comprehensive insight into the genes being regulated 
developmentally by the various methyltransferases. Microarray experiments may also be 
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performed to examine different stages of development in order to determine the timing of 
methylation events and indicate the various processes affected. Furthermore bisulfite 
sequencing of some of the genes, and heterochromatic regions may be carried out to 
determine whether there are significant methylation changes detectable in either form of 
chromatin. These genes, once they have been determined to be affected, will mark the 
starting point for studying promoter methylation changes, dnmt3 targeting, and 
interactions between epigenetic layers. 
These suggested investigations of DNA methylation and its role in notochord 
specification and differentiation will be of special interest given the many unanswered 
questions surrounding neural tube defects and in pmticular the role of DNA methylation 
in these defects. Intriguingly, following 5azadC treatment, zebrafish embryos exhibit a 
shortened body axis, a phenotype commonly associated with convergence extension 
defects (Solnica-Krezel et al. 1996; Weiser et al. 2009). Many neural tube defects have 
been attributed to abberant convergence extension, with the molecular disruptions and 
causes of those disruptions still under investigation (Kibar et al. 2007). These 
connections, in addition to the use of folic acid (a critical factor in the synthesis of the 
methyl group carrier SAM) to prevent neural tube defects (Taparia et al. 2007), certainly 
warrants pursuing 5azadC treated embryos at earlier stages to investigate whether in fact 
convergent extension is affected. These investigations of DNA methylation in 
morphogenesis would represent a novel area of research. 
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